
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Effects of Antiarrhythmic Drugs on hERG Gating in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1 - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="8E598876927655133B8876000595248C.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="frontpharmacol">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8138577/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Frontiers in Pharmacology">
<meta name="citation_title" content="Effects of Antiarrhythmic Drugs on hERG Gating in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1">
<meta name="citation_author" content="Mengying Huang">
<meta name="citation_author_institution" content="First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Mannheim, Germany">
<meta name="citation_author" content="Zhenxing Liao">
<meta name="citation_author_institution" content="First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Mannheim, Germany">
<meta name="citation_author_institution" content="North Sichuan Medical College, Nanchong, China">
<meta name="citation_author" content="Xin Li">
<meta name="citation_author_institution" content="First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Mannheim, Germany">
<meta name="citation_author_institution" content="College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu, China">
<meta name="citation_author" content="Zhen Yang">
<meta name="citation_author_institution" content="First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Mannheim, Germany">
<meta name="citation_author_institution" content="North Sichuan Medical College, Nanchong, China">
<meta name="citation_author" content="Xuehui Fan">
<meta name="citation_author_institution" content="First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Mannheim, Germany">
<meta name="citation_author_institution" content="Key Laboratory of Medical Electrophysiology of Ministry of Education and Medical Electrophysiological Key Laboratory of Sichuan Province, Institute of Cardiovascular Research, Southwest Medical University, Luzhou, China">
<meta name="citation_author" content="Yingrui Li">
<meta name="citation_author_institution" content="First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Mannheim, Germany">
<meta name="citation_author" content="Zhihan Zhao">
<meta name="citation_author_institution" content="First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Mannheim, Germany">
<meta name="citation_author" content="Siegfried Lang">
<meta name="citation_author_institution" content="First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Mannheim, Germany">
<meta name="citation_author_institution" content="DZHK (German Center for Cardiovascular Research), Partner Sites, Heidelberg-Mannheim and Göttingen, Mannheim, Germany">
<meta name="citation_author" content="Lukas Cyganek">
<meta name="citation_author_institution" content="DZHK (German Center for Cardiovascular Research), Partner Sites, Heidelberg-Mannheim and Göttingen, Mannheim, Germany">
<meta name="citation_author_institution" content="Stem Cell Unit, Clinic for Cardiology and Pneumology, University Medical Center Göttingen, Göttingen, Germany">
<meta name="citation_author" content="Xiaobo Zhou">
<meta name="citation_author_institution" content="First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Mannheim, Germany">
<meta name="citation_author_institution" content="Key Laboratory of Medical Electrophysiology of Ministry of Education and Medical Electrophysiological Key Laboratory of Sichuan Province, Institute of Cardiovascular Research, Southwest Medical University, Luzhou, China">
<meta name="citation_author_institution" content="DZHK (German Center for Cardiovascular Research), Partner Sites, Heidelberg-Mannheim and Göttingen, Mannheim, Germany">
<meta name="citation_author" content="Ibrahim Akin">
<meta name="citation_author_institution" content="First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Mannheim, Germany">
<meta name="citation_author_institution" content="DZHK (German Center for Cardiovascular Research), Partner Sites, Heidelberg-Mannheim and Göttingen, Mannheim, Germany">
<meta name="citation_author" content="Martin Borggrefe">
<meta name="citation_author_institution" content="First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Mannheim, Germany">
<meta name="citation_author_institution" content="DZHK (German Center for Cardiovascular Research), Partner Sites, Heidelberg-Mannheim and Göttingen, Mannheim, Germany">
<meta name="citation_author" content="Ibrahim El-Battrawy">
<meta name="citation_author_institution" content="First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Mannheim, Germany">
<meta name="citation_author_institution" content="DZHK (German Center for Cardiovascular Research), Partner Sites, Heidelberg-Mannheim and Göttingen, Mannheim, Germany">
<meta name="citation_publication_date" content="2021 May 7">
<meta name="citation_volume" content="12">
<meta name="citation_firstpage" content="675003">
<meta name="citation_doi" content="10.3389/fphar.2021.675003">
<meta name="citation_pmid" content="34025432">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8138577/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8138577/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8138577/pdf/fphar-12-675003.pdf">
<meta name="description" content="Aims: The short QT syndrome type 1 (SQT1) is linked to hERG channel mutations (e.g., N588K). Drug effects on hERG channel gating kinetics in SQT1-cells have not been investigated. Methods: This study used hiPSC-CMs of a healthy donor and a ...">
<meta name="og:title" content="Effects of Antiarrhythmic Drugs on hERG Gating in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Aims: The short QT syndrome type 1 (SQT1) is linked to hERG channel mutations (e.g., N588K). Drug effects on hERG channel gating kinetics in SQT1-cells have not been investigated. Methods: This study used hiPSC-CMs of a healthy donor and a ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8138577/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="8138577">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.3389/fphar.2021.675003"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/fphar-12-675003.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC8138577%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/8138577/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/8138577/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC8138577/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-frontpharmacol.gif" alt="Frontiers in Pharmacology logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Frontiers in Pharmacology" title="Link to Frontiers in Pharmacology" shape="default" href="http://www.frontiersin.org/pharmacology" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Front Pharmacol</button></div>. 2021 May 7;12:675003. doi: <a href="https://doi.org/10.3389/fphar.2021.675003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.3389/fphar.2021.675003</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Front%20Pharmacol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Front%20Pharmacol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Front%20Pharmacol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Front%20Pharmacol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Effects of Antiarrhythmic Drugs on hERG Gating in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Huang%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Mengying Huang</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Mengying Huang</span></h3>
<div class="p">
<sup><sup>1</sup></sup>First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Mannheim, Germany
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Huang%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mengying Huang</span></a>
</div>
</div>
<sup>1,</sup><sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liao%20Z%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Zhenxing Liao</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Zhenxing Liao</span></h3>
<div class="p">
<sup><sup>1</sup></sup>First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Mannheim, Germany
</div>
<div class="p">
<sup><sup>2</sup></sup>North Sichuan Medical College, Nanchong, China
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liao%20Z%22%5BAuthor%5D" class="usa-link"><span class="name western">Zhenxing Liao</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Xin Li</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Xin Li</span></h3>
<div class="p">
<sup><sup>1</sup></sup>First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Mannheim, Germany
</div>
<div class="p">
<sup><sup>3</sup></sup>College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu, China
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xin Li</span></a>
</div>
</div>
<sup>1,</sup><sup>3,</sup><sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yang%20Z%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Zhen Yang</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Zhen Yang</span></h3>
<div class="p">
<sup><sup>1</sup></sup>First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Mannheim, Germany
</div>
<div class="p">
<sup><sup>2</sup></sup>North Sichuan Medical College, Nanchong, China
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yang%20Z%22%5BAuthor%5D" class="usa-link"><span class="name western">Zhen Yang</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fan%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Xuehui Fan</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Xuehui Fan</span></h3>
<div class="p">
<sup><sup>1</sup></sup>First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Mannheim, Germany
</div>
<div class="p">
<sup><sup>4</sup></sup>Key Laboratory of Medical Electrophysiology of Ministry of Education and Medical Electrophysiological Key Laboratory of Sichuan Province, Institute of Cardiovascular Research, Southwest Medical University, Luzhou, China
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fan%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xuehui Fan</span></a>
</div>
</div>
<sup>1,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Yingrui Li</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Yingrui Li</span></h3>
<div class="p">
<sup><sup>1</sup></sup>First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Mannheim, Germany
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yingrui Li</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20Z%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Zhihan Zhao</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Zhihan Zhao</span></h3>
<div class="p">
<sup><sup>1</sup></sup>First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Mannheim, Germany
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20Z%22%5BAuthor%5D" class="usa-link"><span class="name western">Zhihan Zhao</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lang%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Siegfried Lang</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Siegfried Lang</span></h3>
<div class="p">
<sup><sup>1</sup></sup>First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Mannheim, Germany
</div>
<div class="p">
<sup><sup>5</sup></sup>DZHK (German Center for Cardiovascular Research), Partner Sites, Heidelberg-Mannheim and Göttingen, Mannheim, Germany
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lang%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Siegfried Lang</span></a>
</div>
</div>
<sup>1,</sup><sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cyganek%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Lukas Cyganek</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Lukas Cyganek</span></h3>
<div class="p">
<sup><sup>5</sup></sup>DZHK (German Center for Cardiovascular Research), Partner Sites, Heidelberg-Mannheim and Göttingen, Mannheim, Germany
</div>
<div class="p">
<sup><sup>6</sup></sup>Stem Cell Unit, Clinic for Cardiology and Pneumology, University Medical Center Göttingen, Göttingen, Germany
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cyganek%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lukas Cyganek</span></a>
</div>
</div>
<sup>5,</sup><sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhou%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Xiaobo Zhou</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Xiaobo Zhou</span></h3>
<div class="p">
<sup><sup>1</sup></sup>First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Mannheim, Germany
</div>
<div class="p">
<sup><sup>4</sup></sup>Key Laboratory of Medical Electrophysiology of Ministry of Education and Medical Electrophysiological Key Laboratory of Sichuan Province, Institute of Cardiovascular Research, Southwest Medical University, Luzhou, China
</div>
<div class="p">
<sup><sup>5</sup></sup>DZHK (German Center for Cardiovascular Research), Partner Sites, Heidelberg-Mannheim and Göttingen, Mannheim, Germany
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhou%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xiaobo Zhou</span></a>
</div>
</div>
<sup>1,</sup><sup>4,</sup><sup>5,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Akin%20I%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Ibrahim Akin</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Ibrahim Akin</span></h3>
<div class="p">
<sup><sup>1</sup></sup>First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Mannheim, Germany
</div>
<div class="p">
<sup><sup>5</sup></sup>DZHK (German Center for Cardiovascular Research), Partner Sites, Heidelberg-Mannheim and Göttingen, Mannheim, Germany
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Akin%20I%22%5BAuthor%5D" class="usa-link"><span class="name western">Ibrahim Akin</span></a>
</div>
</div>
<sup>1,</sup><sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Borggrefe%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Martin Borggrefe</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Martin Borggrefe</span></h3>
<div class="p">
<sup><sup>1</sup></sup>First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Mannheim, Germany
</div>
<div class="p">
<sup><sup>5</sup></sup>DZHK (German Center for Cardiovascular Research), Partner Sites, Heidelberg-Mannheim and Göttingen, Mannheim, Germany
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Borggrefe%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Martin Borggrefe</span></a>
</div>
</div>
<sup>1,</sup><sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22El-Battrawy%20I%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Ibrahim El-Battrawy</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Ibrahim El-Battrawy</span></h3>
<div class="p">
<sup><sup>1</sup></sup>First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Mannheim, Germany
</div>
<div class="p">
<sup><sup>5</sup></sup>DZHK (German Center for Cardiovascular Research), Partner Sites, Heidelberg-Mannheim and Göttingen, Mannheim, Germany
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22El-Battrawy%20I%22%5BAuthor%5D" class="usa-link"><span class="name western">Ibrahim El-Battrawy</span></a>
</div>
</div>
<sup>1,</sup><sup>5</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup><sup>1</sup></sup>First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Mannheim, Germany
</div>
<div id="aff2">
<sup><sup>2</sup></sup>North Sichuan Medical College, Nanchong, China
</div>
<div id="aff3">
<sup><sup>3</sup></sup>College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu, China
</div>
<div id="aff4">
<sup><sup>4</sup></sup>Key Laboratory of Medical Electrophysiology of Ministry of Education and Medical Electrophysiological Key Laboratory of Sichuan Province, Institute of Cardiovascular Research, Southwest Medical University, Luzhou, China
</div>
<div id="aff5">
<sup><sup>5</sup></sup>DZHK (German Center for Cardiovascular Research), Partner Sites, Heidelberg-Mannheim and Göttingen, Mannheim, Germany
</div>
<div id="aff6">
<sup><sup>6</sup></sup>Stem Cell Unit, Clinic for Cardiology and Pneumology, University Medical Center Göttingen, Göttingen, Germany
</div>
<div class="author-notes p">
<div class="fn" id="fn1_pmc"><p>
<strong>Edited by:</strong>
<a href="https://loop.frontiersin.org/people/29508/overview" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Eleonora Grandi</a>, University of California, Davis, United States</p></div>
<div class="fn" id="fn2">
<p>
<strong>Reviewed by:</strong>
<a href="https://loop.frontiersin.org/people/649436/overview" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Luca Sala</a>, Istituto Auxologico Italiano, Italy</p>
<p>
<a href="https://loop.frontiersin.org/people/466033/overview" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Michelangelo Paci</a>, Tampere University, Finland</p>
</div>
<div class="fn" id="c001">
<sup>✉</sup><p class="display-inline">*Correspondence: Xiaobo Zhou, <span>Xiaobo.zhou@medma.uni-heidelberg.de</span></p>
</div>
<div class="fn" id="fn1">
<sup><sup>†</sup></sup><p class="display-inline">These authors have contributed equally to this work</p>
</div>
<div class="fn" id="fn4"><p>This article was submitted to Pharmacology of Ion Channels and Channelopathies, a section of the journal Frontiers in Pharmacology</p></div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2021 Mar 2; Accepted 2021 Apr 26; Collection date 2021.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright © 2021 Huang, Liao, Li, Yang, Fan, Li, Zhao, Lang, Cyganek, Zhou, Akin, Borggrefe and El-Battrawy.</div>
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC8138577  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34025432/" class="usa-link">34025432</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>
<strong>Aims:</strong> The short QT syndrome type 1 (SQT1) is linked to hERG channel mutations (e.g., N588K). Drug effects on hERG channel gating kinetics in SQT1-cells have not been investigated.</p>
<p>
<strong>Methods:</strong> This study used hiPSC-CMs of a healthy donor and a SQT1-patient carrying the N588K mutation and patch clamp to examine the drug effects on hERG channel gating kinetics.</p>
<p>
<strong>Results:</strong> Ajmaline, amiodarone, ivabradine, flecainide, quinidine, mexiletine and ranolazine inhibited the hERG channel current (I<sub>Kr</sub>) less strongly in hiPSC-CMs from the SQTS1-patient (SQT1-hiPSC-CMs) comparing with cells from the healthy donor (donor-hiPSC-CMs). Quinidine and mexiletine reduced, but ajmaline, amiodarone, ivabradine and ranolazine increased the time to peak of I<sub>Kr</sub> similarly in SQT1-hiPSC-CMs and donor-hiPSC-CMs. Although regarding the shift of activation and inactivation curves, tested drugs showed differential effects in donor- and SQT1-hiPSC-CMs, quinidine, ajmaline, ivabradine and mexiletine but not amiodarone, flecainide and ranolazine reduced the window current in SQT1-hiPSC-CMs. Quinidine, ajmaline, ivabradine and mexiletine differentially changed the time constant of recovery from inactivation, but all of them increased the time constant of deactivation in SQT1-hiPSC-CMs.</p>
<p>
<strong>Conclusion:</strong> The window current-reducing and deactivation-slowing effects may be important for the antiarrhythmic effect of ajmaline, ivabradine, quinidine and mexiletine in SQT1-cells. This information may be helpful for selecting drugs for treating SQT1-patients with hERG channel mutation.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> short QT syndrome, arrhythmias, antiarrhythmic drugs, human-induced pluripotent stem cell-derived cardiomyocytes, hERG channel</p></section></section><section id="s1"><h2 class="pmc_sec_title">Introduction</h2>
<p>Short QT syndrome (SQTS), described initially by Gussak et al., in 2000 (<a href="#B30" class="usa-link" aria-describedby="B30">Gussak et al., 2000</a>), is a rare, inheritable heart disease associated with abbreviated corrected QT interval (QTc) and sudden cardiac death (SCD). So far, genes reported to be associated with SQTS include KCNH2 (SQTS1), KCNQ1 (SQTS2) and KCNJ2 (SQTS3) (<a href="#B11" class="usa-link" aria-describedby="B11">Campuzano et al., 2018</a>). In addition, a mutation in the cardiac Cl/HCO3 exchanger AE3 has also been reported in patients with SQTS (<a href="#B68" class="usa-link" aria-describedby="B68">Thorsen et al., 2017</a>).</p>
<p>The therapeutic approaches for SQTS are challenging for physicians because of the low prevalence and rare cases. Until now, a small number of drugs including disopyramide, nifekalant, quinidine, flecainide, sotalol, ibutilide and propafenone have been tested by <em>in vivo</em> studies on SQTS1 (<a href="#B1" class="usa-link" aria-describedby="B1">Abriel and Rougier, 2013</a>), among which only quinidine has shown profit effect in the treatment (<a href="#B50" class="usa-link" aria-describedby="B50">Mizobuchi et al., 2008</a>; <a href="#B27" class="usa-link" aria-describedby="B27">Giustetto et al., 2011</a>; <a href="#B42" class="usa-link" aria-describedby="B42">Mazzanti et al., 2017</a>; <a href="#B19" class="usa-link" aria-describedby="B19">El-Battrawy et al., 2018</a>; <a href="#B20" class="usa-link" aria-describedby="B20">El-Battrawy et al., 2019</a>). In human-induced stem cell-derived cardiomyocytes (hiPSC-CMs) from a patient with SQTS type 1, besides quinidine, disopyramide, ajmaline, ivabradine and mexiletine but not sotalol, amiodarone, flecainide and ranolazine showed profitable (APD-prolonging and antiarrhythmic) effects (<a href="#B65" class="usa-link" aria-describedby="B65">Shinnawi et al., 2019</a>; <a href="#B84" class="usa-link" aria-describedby="B84">Zhao et al., 2019</a>; <a href="#B39" class="usa-link" aria-describedby="B39">Lan et al., 2020</a>).</p>
<p>Since SQT1 is caused by an enhanced (a gain-of-function) hERG channel current, hERG channel blockers should be effective for prolonging QT interval or reducing the chance of arrhythmias in SQT1-patients. Surprisingly, some classical hERG channel blockers like sotalol and ibutilide failed to prolong QTc interval in SQT1-patients (<a href="#B26" class="usa-link" aria-describedby="B26">Gaita et al., 2004</a>; <a href="#B20" class="usa-link" aria-describedby="B20">El-Battrawy et al., 2019</a>), suggesting that the mutation in the hERG channel changed the sensitivity of the channel to drugs. Indeed, it was found that some drugs mainly affect hERG channels in the inactivated state and the SQTS1 is caused by a mutation in the hERG channel, which impairs inactivation of the channel and hence reduce the channel sensitivity to those drugs (<a href="#B43" class="usa-link" aria-describedby="B43">McPate et al., 2008</a>). Quinidine affects both the open and inactivated hERG channels and can still inhibit hERG channels even when the inactivation is impaired. This could be an explanation for the failure of some drugs in treating SQTS1. Therefore, numerous studies focused on influences of mutations on channel sensitivity and/or affinity of hERG channels to drugs. However, the sensitivity change cannot explain some phenomena, for example, amiodarone, propafenone and quinidine inhibited N588K-hERG channels in a similar intensity, but only quinidine is effective in prolonging QTc or action potential duration (APD) and suppressing arrhythmic events in SQT1-patients or SQT1-cells (<a href="#B43" class="usa-link" aria-describedby="B43">McPate et al., 2008</a>; <a href="#B84" class="usa-link" aria-describedby="B84">Zhao et al., 2019</a>). This suggests other mechanisms may also play important roles for the efficacy of drugs for SQTS-patients. In our recent studies, using hiPSC-CMs from a patient carrying N588K mutation in hERG channels, we tested the APD-prolonging and antiarrhythmic effects of quinidine, sotalol, ajmaline, amiodarone, ivabradine, flecainide, mexiletine and ranolazine, which are known to be able to inhibit hERG channels. We found that quinidine, ajmaline, ivabradine and mexiletine but not sotalol, amiodarone, flecainide and ranolazine prolonged APD and reduced arrhythmic events in SQT1-hiPSC-CMs (<a href="#B17" class="usa-link" aria-describedby="B17">El-Battrawy et al., 2018</a>; <a href="#B84" class="usa-link" aria-describedby="B84">Zhao et al., 2019</a>), although all of them could inhibit hERG channel currents. Therefore, we hypothesize that not only the channel sensitivity bot also the channel gating kinetics in presence of a drug is important for the efficacy of the drug and the observed differential drug effects may also result from different effects on hERG channel gating kinetics in SQT1-cells. The current study was designed to analyze in detail the effects of quinidine, ajmaline, amiodarone, ivabradine, flecainide, mexiletine and ranolazine on hERG channel gating kinetics in SQT1-hiPSC-CMs.</p></section><section id="s2"><h2 class="pmc_sec_title">Methods</h2>
<section id="s2-1"><h3 class="pmc_sec_title">Ethics Statement and Clinical Data</h3>
<p>A skin biopsy from a SQTS1 patient was obtained with written informed consent from the patient and the Ethics Committee of the Medical Faculty Mannheim, University of Heidelberg (approval numbers: 2018-565N-MA) and the Ethics Committee of University Medical Center Göttingen (approval number: 10/9/15). The study was carried out in accordance with the Helsinki Declaration of 1975 (<a href="https://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki/</a>), revised in 2013.</p></section><section id="s2-2"><h3 class="pmc_sec_title">Generation of Human iPS Cells</h3>
<p>The patient with familial SQTS1 carries the N588K mutation in hERG channel. The clinical data of the patient has been provided in our recent publication (<a href="#B17" class="usa-link" aria-describedby="B17">El-Battrawy et al., 2018</a>).</p>
<p>The methods for the generation of iPS cells (hiPSCs) have been described in our previous study (<a href="#B17" class="usa-link" aria-describedby="B17">El-Battrawy et al., 2018</a>). Briefly, skin fibroblasts from a skin biopsy of the patient and a healthy subject (here defined as donor) were reprogrammed into hiPSC cell line in feeder free culture conditions using the integration-free CytoTune-iPS 2.0 Sendai Reprogramming Kit (Thermo Fisher Scientific, #A16517) and the reprogramming factors OCT4, KLF4, SOX2 and c-MYC. The pluripotency and <em>in vitro</em> differentiation potential of generated hiPSCs were examined as described before (<a href="#B17" class="usa-link" aria-describedby="B17">El-Battrawy et al., 2018</a>). The detailed information is provided in the <a href="#s11" class="usa-link">Supplementary Material</a>.</p></section><section id="s2-3"><h3 class="pmc_sec_title">Generation of hiPSC-CMs</h3>
<p>The hiPSCs were differentiated into cardiomyocytes (hiPSC-CMs) as described in our previous studies (<a href="#B13" class="usa-link" aria-describedby="B13">Cyganek et al., 2018</a>; <a href="#B17" class="usa-link" aria-describedby="B17">El-Battrawy et al., 2018</a>; <a href="#B18" class="usa-link" aria-describedby="B18">El-Battrawy et al., 2018</a>). Briefly (the detailed information is provided in the <a href="#s11" class="usa-link">Supplementary Material</a>), culture dishes were coated with Matrigel (Corning). The medium of TeSR-E8 (Stemcell Technologies) was used for hiPSCs culture and the medium of RPMI1640 Glutamax (Life Technologies) consisting of 1% sodium pyruvate, 1% Penicillin/Streptomycin, ascorbic acid (Sigma Aldrich) and B27 (Life Technologies) was used for hiPSC-CM culture (basic cardiac medium). In the first two weeks, CHIR99021 (Stemgent), BMP-4 (R&amp;DSystems), FGF-2 (MiltenyiBiotec), Activin A (R&amp;D Systems), and IWP-4 (Stemgent) were applied to induce hiPSCs to differentiate into hiPSC-CMs. Normally, on day 8 of differentiation some cells start to beat. In the third week, a selection medium containing sodium lactate (Sigma, Germany) and RPMI medium without glucose and glutamine (WKS, Germany) was used to select cardiomyocytes. Afterward, the selected cells were cultured with basic cardiac medium. After 40 to 60 days of differentiation, the cardiomyocytes were dissociated from 6 well plates and plated on Matrigel-coated 3.5 cm petri dishes as single cells for patch clamp tests. In our lab, the differentiation of hiPS cells into iPSC-CMs is regularly carried out every 2–3 weeks. The hiPSC-CMs from several differentiations were used for studies and the data were combined. Two clones of the hiPSCs were alternately differentiated into hiPSC-CMs.</p></section><section id="s2-4"><h3 class="pmc_sec_title">Patch-Clamp</h3>
<p>Standard patch-clamp whole-cell recording techniques were used to measure the hERG channel currents at room temperature. Patch electrodes were pulled from borosilicate glass capillaries (MTW 150F; world Precision Instruments, Inc., Sarasota, FL) using a DMZ-Universal Puller (Zeitz-Instrumente Vertriebs GmbH, Martinsried, Germany) and filled with pre-filtered pipette solution (see below). Pipette resistance ranged from 1–2 MΩ. Signals were acquired at 10 kHz and filtered at 2 kHz with the EPC10 Patch-master digitizer hardware (HEKA Germany) and Fit-master software (HEKA Germany).</p>
<p>To separate the hERG channel current from other currents, the Cs<sup>+</sup> currents conducted by hERG channels (I<sub>Kr</sub>) were measured. External solution contains (mM): 140 CsCl, 2 MgCl2, 10 HEPES, 10 Glucose, pH = 7.4 (CsOH). Pipette solution: 140 CsCl, 2 MgCl2, 10 HEPES, 10 EGTA, pH=7.2 (CsOH).</p></section><section id="s2-5"><h3 class="pmc_sec_title">Drugs</h3>
<p>Ivabradine, flecainide, amiodarone, mexiletine, quinidine, and ranolazine were from Sigma, ajmaline from MP Biomedicals. The tested concentrations were selected according to literatures and our previous studies in hiPSC-CMs (<a href="#B76" class="usa-link" aria-describedby="B76">Wu et al., 2004</a>; <a href="#B17" class="usa-link" aria-describedby="B17">El-Battrawy et al., 2018</a>; <a href="#B59" class="usa-link" aria-describedby="B59">Salvage et al., 2018</a>; <a href="#B84" class="usa-link" aria-describedby="B84">Zhao et al., 2019</a>). Our previous studies showed that 10 µM quinidine, 10 µM ivabradine, 30 µM ajmaline, 100 µM mexiletine, prolonged APD, 10 µM amiodarone inhibited I<sub>Kr</sub> (<a href="#B17" class="usa-link" aria-describedby="B17">El-Battrawy et al., 2018</a>; <a href="#B84" class="usa-link" aria-describedby="B84">Zhao et al., 2019</a>). Ranolazine (5–30 µM) significantly reduced episodes of EADs and VT produced by ATX-II (<a href="#B76" class="usa-link" aria-describedby="B76">Wu et al., 2004</a>). Flecainide of 3–30 µM was shown to inhibit Na and K channel currents (<a href="#B59" class="usa-link" aria-describedby="B59">Salvage et al., 2018</a>). Therefore, the concentrations of 10 µM quinidine, 30 µM ajmaline, 10 µM amiodarone, 10 µM ivabradine, 30 µM flecainide, 100 µM mexiletine and 30 µM ranolazine were chosen for the study. Of note, all these drugs can affect other channel currents besides hERG channel currents (<a href="#s11" class="usa-link">Supplementary Table 1</a>).</p></section><section id="s2-6"><h3 class="pmc_sec_title">Statistical Analysis</h3>
<p>Data are shown as mean ± SEM and were analyzed using InStat<sup>©</sup> (GraphPad, San Diego, United States) and SigmaPlot 11.0 (Systat GmbH, Germany). The t-test was used for comparison between two independent groups. Paired t-test was used for comparisons of data in the same cells before and after application of a drug. One way ANOVA was used for comparison among multiple groups (more than two groups). <em>p</em> &lt; 0.05 (two-tailed) was considered significant.</p></section></section><section id="s3"><h2 class="pmc_sec_title">Results</h2>
<section id="s3-1"><h3 class="pmc_sec_title">Drug Effects on hERG Channel Currents in hiPSC-CMs</h3>
<p>In our recent study, we demonstrated that quinidine, ajmaline, amiodarone, ivabradine, and mexiletine but not amiodarone, flecainide and ranolazine prolonged APD and reduced epinephrine induced arrhythmic events in hiPSC-CMs from the SQT1-patient (SQT1-hiPSC-CMs) (<a href="#B84" class="usa-link" aria-describedby="B84">Zhao et al., 2019</a>).To check whether these drugs affect hERG channel currents (I<sub>Kr</sub>) differentially in hiPSC-CMs from healthy donor and the SQTS1-patient, drug effects on I<sub>Kr</sub> were analyzed in both the healthy and diseased cells. I<sub>Kr</sub> amplitudes and current-voltage relationship (I-V) curves in the same cells before and after application of a drug were analyzed. <a href="#F1" class="usa-link">Figures 1A–D</a> showed effects of quinidine as examples of drug effects. Quinidine reduced the peak and steady state current of I<sub>Kr</sub> (<a href="#F1" class="usa-link">Figures 1,B</a>) at different potentials (<a href="#F1" class="usa-link">Figures 1C,D</a>). All the tested seven drugs inhibited I<sub>Kr</sub> in both donor- and SQT1-hiPSC-CMs. However, the inhibition induced by drugs was reduced in SQT1-hiPSC-CMs. Especially, the effect of amiodarone, flecainide, mexiletine and ranolazine was more severely reduced in SQT1-hiPSC-CMs (<a href="#F1" class="usa-link">Figure 1E</a>, <a href="#T1" class="usa-link">Table 1</a>).</p>
<figure class="fig xbox font-sm" id="F1"><h4 class="obj_head">FIGURE 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8138577_fphar-12-675003-g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e0/8138577/2a87119701c2/fphar-12-675003-g001.jpg" loading="lazy" height="495" width="708" alt="FIGURE 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/F1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Drug effects on I<sub>Kr</sub> in SQTS1-hiPSC-CMs. I<sub>Kr</sub> was evoked by 2 s pulses from −80 to 60 mV (10 mV increments) with a holding potential of −80 mV. The steady state currents were measured at the end of pulses as indicated by arrows in <strong>(A)</strong> and <strong>(B)</strong> in the same cells before and after application of a drug. <strong>(A)</strong> The protocol <strong>(right side)</strong> and representative I<sub>Kr</sub> traces <strong>(left side)</strong> in absence (Control) and presence of 10 µM quinidine (Qui) in a SQT1-hiPSC-CM (SQT). <strong>(B)</strong> Representative I<sub>Kr</sub> traces in absence (Control) and presence of 10 µM quinidine (Qui) in a donor-hiPSC-CM (Healthy). <strong>(C)</strong> Current-voltage relationship (I-V) curves of I<sub>Kr</sub> in absence (Control) and presence of 10 µM quinidine (Qui) in SQT1-hiPSC-CMs (SQT). <strong>(D)</strong> I-V curves of I<sub>Kr</sub> in absence (Control) and presence of 10 µM quinidine (Qui) in donor-hiPSC-CMs (Healthy). <strong>(E)</strong> Averaged values of percent inhibition of I<sub>Kr</sub> at 40 mV by quinidine (Qui, 10 µM), ajmaline (Ajm, 30 µM), amiodarone (Ami, 10 µM), ivabradine (Iva, 10 µM), flecainide (Fle, 30 µM), mexiletine (Mex, 100 µM) and ranolazine (Ran, 30 µM) in hiPSC-CMs from a healthy subject (Donor) and the patient (SQT). The inhibition was calculated by: Inhibition = (I<sub>ctr</sub>−I<sub>drug</sub>)/I<sub>ctr</sub>*100, where I<sub>ctr</sub> is the current before application of a drug, I<sub>drug</sub> is the steady state current in presence of a drug. Shown are mean ± SEM, <em>n</em> represents number of measured cells. The statistical significance was examined by paired t-test <strong>(C, D)</strong> or unpaired t-test <strong>(E)</strong>, *<em>p</em> &lt; 0.05.</p></figcaption></figure><section class="tw xbox font-sm" id="T1"><h4 class="obj_head">TABLE 1.</h4>
<div class="caption p"><p>Summary of drug effects on I<sub>Kr</sub> and APD/QT.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead valign="top">
<tr>
<th rowspan="2" align="left" colspan="1"></th>
<th colspan="2" align="center" rowspan="1">Inhb (%)</th>
<th colspan="2" align="center" rowspan="1">T-P</th>
<th colspan="2" align="center" rowspan="1">Vh-act</th>
<th colspan="2" align="center" rowspan="1">τ-inact</th>
<th colspan="2" align="center" rowspan="1">Vh-inact</th>
<th colspan="2" align="center" rowspan="1">Win-cur</th>
<th colspan="2" align="center" rowspan="1">τ-rec</th>
<th colspan="2" align="center" rowspan="1">τ-deact</th>
<th colspan="2" align="center" rowspan="1">APD/QT-lit</th>
</tr>
<tr>
<th align="center" rowspan="1" colspan="1">SQT</th>
<th align="center" rowspan="1" colspan="1">H</th>
<th align="center" rowspan="1" colspan="1">SQT</th>
<th align="center" rowspan="1" colspan="1">H</th>
<th align="center" rowspan="1" colspan="1">SQT</th>
<th align="center" rowspan="1" colspan="1">H</th>
<th align="center" rowspan="1" colspan="1">SQT</th>
<th align="center" rowspan="1" colspan="1">H</th>
<th align="center" rowspan="1" colspan="1">SQT</th>
<th align="center" rowspan="1" colspan="1">H</th>
<th align="center" rowspan="1" colspan="1">SQT</th>
<th align="center" rowspan="1" colspan="1">H</th>
<th align="center" rowspan="1" colspan="1">SQT</th>
<th align="center" rowspan="1" colspan="1">H</th>
<th align="center" rowspan="1" colspan="1">SQT</th>
<th align="center" rowspan="1" colspan="1">H</th>
<th align="center" rowspan="1" colspan="1">SQT</th>
<th align="center" rowspan="1" colspan="1">H</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" rowspan="1" colspan="1">Qui</td>
<td align="center" rowspan="1" colspan="1">55</td>
<td align="center" rowspan="1" colspan="1">68</td>
<td align="center" rowspan="1" colspan="1">−</td>
<td align="center" rowspan="1" colspan="1">−</td>
<td align="center" rowspan="1" colspan="1">R</td>
<td align="center" rowspan="1" colspan="1">R</td>
<td align="center" rowspan="1" colspan="1">N</td>
<td align="center" rowspan="1" colspan="1">+</td>
<td align="center" rowspan="1" colspan="1">L</td>
<td align="center" rowspan="1" colspan="1">L</td>
<td align="center" rowspan="1" colspan="1">−</td>
<td align="center" rowspan="1" colspan="1">−</td>
<td align="center" rowspan="1" colspan="1">+</td>
<td align="center" rowspan="1" colspan="1">+</td>
<td align="center" rowspan="1" colspan="1">+</td>
<td align="center" rowspan="1" colspan="1">+</td>
<td align="left" rowspan="1" colspan="1">P (<a href="#B29" class="usa-link" aria-describedby="B29">Guo et al., 2019</a>)</td>
<td align="left" rowspan="1" colspan="1">P (<a href="#B14" class="usa-link" aria-describedby="B14">Davidenko et al., 1989</a>)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ajm</td>
<td align="center" rowspan="1" colspan="1">34</td>
<td align="center" rowspan="1" colspan="1">64</td>
<td align="center" rowspan="1" colspan="1">+</td>
<td align="center" rowspan="1" colspan="1">+</td>
<td align="center" rowspan="1" colspan="1">R</td>
<td align="center" rowspan="1" colspan="1">R</td>
<td align="center" rowspan="1" colspan="1">+</td>
<td align="center" rowspan="1" colspan="1">+</td>
<td align="center" rowspan="1" colspan="1">L</td>
<td align="center" rowspan="1" colspan="1">L</td>
<td align="center" rowspan="1" colspan="1">−</td>
<td align="center" rowspan="1" colspan="1">−</td>
<td align="center" rowspan="1" colspan="1">−</td>
<td align="center" rowspan="1" colspan="1">N</td>
<td align="center" rowspan="1" colspan="1">+</td>
<td align="center" rowspan="1" colspan="1">N</td>
<td align="left" rowspan="1" colspan="1">P (<a href="#B84" class="usa-link" aria-describedby="B84">Zhao et al., 2019</a>; <a href="#B34" class="usa-link" aria-describedby="B34">Jæger et al., 2021</a>)</td>
<td align="left" rowspan="1" colspan="1">P (<a href="#B5" class="usa-link" aria-describedby="B5">Bébarová et al., 2005a</a>)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ami</td>
<td align="center" rowspan="1" colspan="1">19</td>
<td align="center" rowspan="1" colspan="1">46</td>
<td align="center" rowspan="1" colspan="1">+</td>
<td align="center" rowspan="1" colspan="1">+</td>
<td align="center" rowspan="1" colspan="1">N</td>
<td align="center" rowspan="1" colspan="1">R</td>
<td align="center" rowspan="1" colspan="1">−</td>
<td align="center" rowspan="1" colspan="1">+</td>
<td align="center" rowspan="1" colspan="1">N</td>
<td align="center" rowspan="1" colspan="1">R</td>
<td align="center" rowspan="1" colspan="1">N</td>
<td align="center" rowspan="1" colspan="1">N</td>
<td align="center" rowspan="1" colspan="1">−</td>
<td align="center" rowspan="1" colspan="1">−</td>
<td align="center" rowspan="1" colspan="1">N</td>
<td align="center" rowspan="1" colspan="1">−</td>
<td align="center" rowspan="1" colspan="1">N (<a href="#B27" class="usa-link" aria-describedby="B27">Giustetto et al., 2011</a>)</td>
<td align="left" rowspan="1" colspan="1">N (<a href="#B4" class="usa-link" aria-describedby="B4">Aomine, 1988</a>; <a href="#B61" class="usa-link" aria-describedby="B61">Sasaki et al., 2014</a>), P (<a href="#B4" class="usa-link" aria-describedby="B4">Aomine, 1988</a>)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Iva</td>
<td align="center" rowspan="1" colspan="1">41</td>
<td align="center" rowspan="1" colspan="1">68</td>
<td align="center" rowspan="1" colspan="1">+</td>
<td align="center" rowspan="1" colspan="1">+</td>
<td align="center" rowspan="1" colspan="1">R</td>
<td align="center" rowspan="1" colspan="1">R</td>
<td align="center" rowspan="1" colspan="1">−</td>
<td align="center" rowspan="1" colspan="1">−</td>
<td align="center" rowspan="1" colspan="1">L</td>
<td align="center" rowspan="1" colspan="1">R</td>
<td align="center" rowspan="1" colspan="1">−</td>
<td align="center" rowspan="1" colspan="1">N</td>
<td align="center" rowspan="1" colspan="1">N</td>
<td align="center" rowspan="1" colspan="1">+</td>
<td align="center" rowspan="1" colspan="1">+</td>
<td align="center" rowspan="1" colspan="1">+</td>
<td align="left" rowspan="1" colspan="1">P (<a href="#B24" class="usa-link" aria-describedby="B24">Frommeyer et al., 2017</a>)</td>
<td align="left" rowspan="1" colspan="1">N (<a href="#B31" class="usa-link" aria-describedby="B31">Haechl et al., 2019</a>), S (<a href="#B38" class="usa-link" aria-describedby="B38">Koncz et al., 2011</a>), P (<a href="#B38" class="usa-link" aria-describedby="B38">Koncz et al., 2011</a>)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Fle</td>
<td align="center" rowspan="1" colspan="1">21</td>
<td align="center" rowspan="1" colspan="1">71</td>
<td align="center" rowspan="1" colspan="1">N</td>
<td align="center" rowspan="1" colspan="1">+</td>
<td align="center" rowspan="1" colspan="1">N</td>
<td align="center" rowspan="1" colspan="1">N</td>
<td align="center" rowspan="1" colspan="1">+</td>
<td align="center" rowspan="1" colspan="1">+</td>
<td align="center" rowspan="1" colspan="1">N</td>
<td align="center" rowspan="1" colspan="1">L</td>
<td align="center" rowspan="1" colspan="1">N</td>
<td align="center" rowspan="1" colspan="1">N</td>
<td align="center" rowspan="1" colspan="1">+</td>
<td align="center" rowspan="1" colspan="1">N</td>
<td align="center" rowspan="1" colspan="1">N</td>
<td align="center" rowspan="1" colspan="1">N</td>
<td align="left" rowspan="1" colspan="1">N (<a href="#B26" class="usa-link" aria-describedby="B26">Gaita et al., 2004</a>)</td>
<td align="left" rowspan="1" colspan="1">P (<a href="#B8" class="usa-link" aria-describedby="B8">Borchard and Boisten, 1982</a>; <a href="#B71" class="usa-link" aria-describedby="B71">Wang et al., 1993</a>)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Mex</td>
<td align="center" rowspan="1" colspan="1">25</td>
<td align="center" rowspan="1" colspan="1">60</td>
<td align="center" rowspan="1" colspan="1">−−</td>
<td align="center" rowspan="1" colspan="1">−</td>
<td align="center" rowspan="1" colspan="1">N</td>
<td align="center" rowspan="1" colspan="1">R</td>
<td align="center" rowspan="1" colspan="1">N</td>
<td align="center" rowspan="1" colspan="1">−</td>
<td align="center" rowspan="1" colspan="1">L</td>
<td align="center" rowspan="1" colspan="1">L</td>
<td align="center" rowspan="1" colspan="1">−</td>
<td align="center" rowspan="1" colspan="1">−</td>
<td align="center" rowspan="1" colspan="1">−</td>
<td align="center" rowspan="1" colspan="1">N</td>
<td align="center" rowspan="1" colspan="1">+</td>
<td align="center" rowspan="1" colspan="1">+</td>
<td align="left" rowspan="1" colspan="1">P (<a href="#B25" class="usa-link" aria-describedby="B25">Frommeyer et al., 2018</a>)</td>
<td align="left" rowspan="1" colspan="1">S (<a href="#B41" class="usa-link" aria-describedby="B41">Matsuo et al., 1985</a>; <a href="#B62" class="usa-link" aria-describedby="B62">Sato et al., 1995</a>)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ran</td>
<td align="center" rowspan="1" colspan="1">11</td>
<td align="center" rowspan="1" colspan="1">71</td>
<td align="center" rowspan="1" colspan="1">+</td>
<td align="center" rowspan="1" colspan="1">+</td>
<td align="center" rowspan="1" colspan="1">L</td>
<td align="center" rowspan="1" colspan="1">L</td>
<td align="center" rowspan="1" colspan="1">+</td>
<td align="center" rowspan="1" colspan="1">−</td>
<td align="center" rowspan="1" colspan="1">L</td>
<td align="center" rowspan="1" colspan="1">L</td>
<td align="center" rowspan="1" colspan="1">N</td>
<td align="center" rowspan="1" colspan="1">N</td>
<td align="center" rowspan="1" colspan="1">N</td>
<td align="center" rowspan="1" colspan="1">+</td>
<td align="center" rowspan="1" colspan="1">N</td>
<td align="center" rowspan="1" colspan="1">N</td>
<td align="left" rowspan="1" colspan="1">P (<a href="#B23" class="usa-link" aria-describedby="B23">Frommeyer et al., 2016</a>), N (<a href="#B84" class="usa-link" aria-describedby="B84">Zhao et al., 2019</a>)</td>
<td align="left" rowspan="1" colspan="1">P (<a href="#B76" class="usa-link" aria-describedby="B76">Wu et al., 2004</a>), S (<a href="#B2" class="usa-link" aria-describedby="B2">Antzelevitch et al., 2004a</a>)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="fn5"><p>I<sub>Kr</sub>: rapidly activating delay rectifier K (hERG) channel current. APD: action potential duration. SQT: SQT cells. H: healthy (wild-type) cells. Qui: quinidine. Ajm: ajmaline. Ami: amiodarone. Iva: ivabradine. Fle: flecainide. Mex: mexiletine. Ran: ranolazine. Inhb: inhibition induced by a drug. T-P: time to peak of I<sub>Kr</sub>. Vh-act: voltage at half maximal activation of I<sub>Kr</sub>. τ-inact: time constant of inactivation of I<sub>Kr</sub>. Vh-inact: voltage at half maximal inactivation of I<sub>Kr</sub>. Win-cur: window current of I<sub>Kr</sub>. τ-rec: time constant of recovery from inactivation of I<sub>Kr</sub>. APD/QT-lit: changes of APD or QT interval induced by the drug reported in literatures.</p></div>
<div class="fn" id="fn6"><p>“−”: decrease. “+”: increase. N: No effect. R: Shift to a more positive potential (A shift to the right). L: Shift to a more negative potential (A shift to the left). P: Prolongation. S: shortening.</p></div>
</div></section></section><section id="s3-2"><h3 class="pmc_sec_title">Drug Effects on Activation of I<sub>Kr</sub> in hiPSC-CMs</h3>
<p>To examine the effects of drugs on I<sub>Kr</sub> activation, the time to peak (T-p) and activation curves were analyzed (<a href="#T1" class="usa-link">Table 1</a>). Quinidine (<a href="#F2" class="usa-link">Figures 2A,H,I,P</a>) and mexiletine (<a href="#F2" class="usa-link">Figures 2F,H,N,P</a>) accelerated (T-p was reduced), while ajmaline (<a href="#F2" class="usa-link">Figures 2B,H,J,P</a>), amiodarone (<a href="#F2" class="usa-link">Figures 2C,H,K,P</a>), ivabradine (<a href="#F2" class="usa-link">Figures 2D,H,L,P</a>) and ranolazine (<a href="#F2" class="usa-link">Figures 2G,H,O,P</a>) decelerated (T-p was increased) the I<sub>Kr</sub> activation in donor- and SQTS1-hiPSC-CMs. Flecainide showed no effect in SQT1-hiPSC-CMs (<a href="#F2" class="usa-link">Figures 2E,H</a>), but increased T-p in donor-hiPSC-CMs (<a href="#F2" class="usa-link">Figures 2M,P</a>).</p>
<figure class="fig xbox font-sm" id="F2"><h4 class="obj_head">FIGURE 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8138577_fphar-12-675003-g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e0/8138577/5306f07bfb86/fphar-12-675003-g002.jpg" loading="lazy" height="552" width="708" alt="FIGURE 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/F2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Drug effects on the time to peak of I<sub>Kr</sub> in SQTS1-hiPSC-CMs. The time to peak (the time between the start of a pulse to the highest peak current point) of I<sub>Kr</sub> was measured in current traces from 10 to 80 mV and plotted against voltages. The same cells before and after application of a drug were measured. <strong>(A–G)</strong> Representative curves of time to peak in SQT1-hiPSC-CMs in absence (Ctr) and presence of quinidine (Qui, 10 µM), ajmaline (Ajm, 30 µM), amiodarone (Ami, 10 µM), ivabradine (Iva, 10 µM), flecainide (Fle, 30 µM), mexiletine (Mex, 100 µM) and ranolazine (Ran, 30 µM). <strong>(H)</strong> Averaged values of time to peak at 20 mV in SQT1-hiPSC-CMs in absence (Ctr) and presence of drugs. <strong>(I–O)</strong> Representative curves of time to peak in donor-hiPSC-CMs in absence (Ctr) and presence of quinidine (Qui, 10 µM), ajmaline (Ajm, 30 µM), amiodarone (Ami, 10 µM), ivabradine (Iva, 10 µM), flecainide (Fle, 30 µM), mexiletine (Mex, 100 µM) and ranolazine (Ran, 30 µM). <strong>(P)</strong> Averaged values of time to peak at 20 mV in donor-hiPSC-CMs in absence (Ctr) and presence of drugs. Shown are mean ± SEM, <em>n</em> represents number of cells. The statistical significance was examined by paired t-test, *<em>p</em> &lt; 0.05 versus Control.</p></figcaption></figure><p>In SQT1-hiPSC-CMs, quinidine, ajmaline and ivabradine shifted the activation curve of I<sub>Kr</sub> to more positive potentials (<a href="#F3" class="usa-link">Figures 3A,B,D,H</a>), whereas ranolazine shifted the activation curve to more negative potentials (<a href="#F3" class="usa-link">Figures 3G,H</a>). Amiodarone, flecainide and mexiletine showed no effect (<a href="#F3" class="usa-link">Figures 3C,E–H</a>). In donor cells, quinidine, ajmaline, amiodarone, ivabradine and mexiletine shifted the activation curves to more positive potentials (<a href="#F3" class="usa-link">Figures 3I–L,N,P</a>), while ranolazine showed an opposite effect (<a href="#F3" class="usa-link">Figures 3O,P</a>). Flecainide showed no significant effect (<a href="#F3" class="usa-link">Figures 3M,P</a>).</p>
<figure class="fig xbox font-sm" id="F3"><h4 class="obj_head">FIGURE 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8138577_fphar-12-675003-g003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e0/8138577/ae90900061e7/fphar-12-675003-g003.jpg" loading="lazy" height="568" width="708" alt="FIGURE 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/F3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Drug effects on voltage-dependent activation of I<sub>Kr</sub> in SQTS1-hiPSC-CMs. I<sub>Kr</sub> was evoked by 2 s pulses from −80 to 60 mV (10 mV increments) with a holding potential of −80 mV. The steady state currents were measured at the end of pulses as indicated by arrows in <a href="#F1" class="usa-link">Figures 1A,B</a> before and after application of a drug. The conductance was calculated with the equation: G = I/V, where I is the measured current, V is the voltage of pulses and G is the conductance. The conductance was normalized to the maximum (G/Gmax) and plotted against voltage to obtain the activation (G-V) curves. The curves were fitted by Boltzmann equation to obtain the voltage value at half maximal activation (V0.5). <strong>(A–G)</strong> Activation curves of I<sub>Kr</sub> in SQT1-hiPSC-CMs in absence (Ctr) and presence of quinidine (Qui, 10 µM), ajmaline (Ajm, 30 µM), amiodarone (Ami, 10 µM), ivabradine (Iva, 10 µM), flecainide (Fle, 30 µM), mexiletine (Mex, 100 µM) and ranolazine (Ran, 30 µM). <strong>(H)</strong> Averaged values of half maximal activation potential (V0.5) in SQT1-hiPSC-CMs in absence (Ctr) and presence of drugs. <strong>(I–O)</strong> Activation curves of I<sub>Kr</sub> in donor-hiPSC-CMs in absence (Ctr) and presence of quinidine (Qui, 10 µM), ajmaline (Ajm, 30 µM), amiodarone (Ami, 10 µM), ivabradine (Iva, 10 µM), flecainide (Fle, 30 µM), mexiletine (Mex, 100 µM) and ranolazine (Ran, 30 µM). <strong>(P)</strong> Averaged values of half maximal activation potential (V0.5) in donor-hiPSC-CMs in absence (Ctr) and presence of drugs. Shown are mean ± SEM, <em>n</em> represents number of cells. The statistical significance was examined by paired t-test, *<em>p</em> &lt; 0.05 versus Control.</p></figcaption></figure></section><section id="s3-3"><h3 class="pmc_sec_title">Drug Effects on Inactivation of I<sub>Kr</sub> in hiPSC-CMs</h3>
<p>To examine drug effects on I<sub>Kr</sub> inactivation, the inactivation curves of I<sub>Kr</sub> and the time constant (τ) of the current decay due to channel inactivation were analyzed (<a href="#T1" class="usa-link">Table 1</a>). The inactivation curves were shifted to more negative potentials by quinidine (<a href="#F4" class="usa-link">Figures 4A,H</a>), ajmaline (<a href="#F4" class="usa-link">Figures 4B,H</a>), ivabradine (<a href="#F4" class="usa-link">Figures 4D,H</a>), mexiletine (<a href="#F4" class="usa-link">Figures 4F,H</a>), and ranolazine (<a href="#F4" class="usa-link">Figures 4G,H</a>) but not significantly influenced by amiodarone (<a href="#F4" class="usa-link">Figures 4C,H</a>) and flecainide (<a href="#F4" class="usa-link">Figures 4E,H</a>) in SQT1-hiPSC-CMs. In donor cells, the inactivation curves were shifted to more negative potentials by quinidine (<a href="#F4" class="usa-link">Figures 4I,P</a>), ajmaline (<a href="#F4" class="usa-link">Figures 4J,P</a>), flecainide (<a href="#F4" class="usa-link">Figures 4M,P</a>), mexiletine (<a href="#F4" class="usa-link">Figures 4N,P</a>) and ranolazine (<a href="#F4" class="usa-link">Figures 4O,P</a>) and to more positive potentials by amiodarone (<a href="#F4" class="usa-link">Figures 4K,P</a>) and ivabradine (<a href="#F4" class="usa-link">Figures 4L,P</a>).</p>
<figure class="fig xbox font-sm" id="F4"><h4 class="obj_head">FIGURE 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8138577_fphar-12-675003-g004.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e0/8138577/b50399732acf/fphar-12-675003-g004.jpg" loading="lazy" height="524" width="708" alt="FIGURE 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/F4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Drug effects on voltage-dependent inactivation of I<sub>Kr</sub> in SQTS1-hiPSC-CMs. I<sub>Kr</sub> was evoked by the protocol shown in A <strong>(right panel)</strong>. A pre-pulse of 1 s from −80 mV (the holding potential) to +60 mV followed by a short (20 ms) repolarization to −100 mV was given for channel activation, inactivation and recovery of inactivated channels to open state. Before deactivation occurs, test pulses of 1°s from −50 to +80 mV (10 mV increments) were started to evaluate the inactivation of channels. I<sub>Kr</sub> was measured at the beginning (peak current, a) and end (steady current, b) of test pulses as shown in A <strong>(right panel)</strong>. The currents in same cells before and after application of a drug were measured. The current of inactivated channels (I<sub>inact</sub>) was calculated as: I<sub>inact</sub> =Ia-Ib, where Ia is the peak current, Ib is the steady current. When I<sub>inact</sub> is larger than zero, it means inactivation occurred. When I<sub>inact</sub> equals or is smaller than zero, it means no inactivation occurred. I<sub>inact</sub> at different potentials were measured and normalized to the maximal current (I<sub>inactMax</sub>). To plot the inactivation curves as usually shown (the curve decays with increasing voltages), the relative current was calculated by I=1 − I<sub>inact</sub>/I<sub>inactMax</sub>. Finally, I was normalized to the maximal value I<sub>max</sub> and plotted against voltages to obtain an inactivation curve. The inactivation curves were then fitted by Boltzmann equation to obtain the voltage value at half maximal inactivation (V0.5). <strong>(A–G)</strong> Inactivation curves of I<sub>Kr</sub> in SQT1-hiPSC-CMs in absence (Ctr) and presence of quinidine (Qui, 10 µM), ajmaline (Ajm, 30 µM), amiodarone (Ami, 10 µM), ivabradine (Iva, 10 µM), flecainide (Fle, 30 µM), mexiletine (Mex, 100 µM) and ranolazine (Ran, 30 µM). <strong>(H)</strong> Averaged values of half maximal inactivation potential (V0.5) in SQT1-hiPSC-CMs in absence (Ctr) and presence of drugs. <strong>(I–O)</strong> Inactivation curves of I<sub>Kr</sub> in donor-hiPSC-CMs in absence (Ctr) and presence of quinidine (Qui, 10 µM), ajmaline (Ajm, 30 µM), amiodarone (Ami, 10 µM), ivabradine (Iva, 10 µM), flecainide (Fle, 30 µM), mexiletine (Mex, 100 µM) and ranolazine (Ran, 30 µM). <strong>(P)</strong> Averaged values of half maximal inactivation potential (V0.5) in donor-hiPSC-CMs in absence (Ctr) and presence of drugs. Shown are mean ± SEM, <em>n</em> represents number of cells. The statistical significance was examined by paired t-test, *<em>p</em> &lt; 0.05 versus Control.</p></figcaption></figure><p>In addition, it was detected that in SQT1-hiPSC-CMs, ajmaline (<a href="#F5" class="usa-link">Figure 5C</a>), flecainide (<a href="#F5" class="usa-link">Figure 5F</a>) and ranolazine (<a href="#F5" class="usa-link">Figure 5H</a>) decelerated the inactivation (time constant was increased), while amiodarone (<a href="#F5" class="usa-link">Figure 5D</a>) and ivabradine (<a href="#F5" class="usa-link">Figure 5E</a>) accelerated it. Quinidine (<a href="#F5" class="usa-link">Figure 5B</a>) and mexiletine (<a href="#F5" class="usa-link">Figure 5G</a>) had no significant effects. In donor-hiPSC-CMs, quinidine (<a href="#F5" class="usa-link">Figure 5J</a>), ajmaline (<a href="#F5" class="usa-link">Figure 5K</a>), amiodarone (<a href="#F5" class="usa-link">Figure 5L</a>) and flecainide (<a href="#F5" class="usa-link">Figure 5N</a>) decelerated the inactivation, while ivabradine (<a href="#F5" class="usa-link">Figure 5M</a>), mexiletine (<a href="#F5" class="usa-link">Figure 5O</a>) and ranolazine (<a href="#F5" class="usa-link">Figure 5P</a>) accelerated it. <a href="#F5" class="usa-link">Figures 5A,I</a> show examples of current inactivation in absence and presence of a drug (quinidine).</p>
<figure class="fig xbox font-sm" id="F5"><h4 class="obj_head">FIGURE 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8138577_fphar-12-675003-g005.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e0/8138577/1894cc229fa4/fphar-12-675003-g005.jpg" loading="lazy" height="564" width="708" alt="FIGURE 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/F5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Drug effects on the time constant of I<sub>Kr</sub> inactivation in SQTS1-hiPSC-CMs. To examine drug effects on the fast phase of inactivation, I<sub>Kr</sub> was evoked by a 1 s-long pre-pulse from −80 to 60 mV to let hERG channels be activated and returned to −100 mV for 20 ms, and then the pre-pulse was followed by 500 ms test-pulses [P4 in the protocol shown by the inset in <strong>(A)</strong> and <strong>(I)</strong>] from 20 to 80 mV (10 mV increments). Currents evoked by test pulses were fitted by single exponential decay to obtain the time constant (τ) of I<sub>Kr</sub> fast inactivation. <strong>(A)</strong> Representative traces of I<sub>Kr</sub> evoked by pulses from 20 to 80 mV in absence (Control) and presence of 10 µM quinidine (Qui) in a SQT1-hiPSC-CM. <strong>(B–H)</strong> Mean values of time constants (τ) of I<sub>Kr</sub> inactivation in SQT1-hiPSC-CMs in absence (Ctr) and presence of quinidine (Qui, 10 µM), ajmaline (Ajm, 30 µM), amiodarone (Ami, 10 µM), ivabradine (Iva, 10 µM), flecainide (Fle, 30 µM), mexiletine (Mex, 100 µM) and ranolazine (Ran, 30 µM). <strong>(I)</strong> Representative traces of I<sub>Kr</sub> evoked by pulses from 20 to 80 mV in absence (Control) and presence of 10 µM quinidine (Qui) in a donor-hiPSC-CM. <strong>(J–P)</strong> Mean values of time constants (τ) of I<sub>Kr</sub> inactivation in donor-hiPSC-CMs in absence (Ctr) and presence of each drug. Shown are mean ± SEM, <em>n</em> represents number of cells. The statistical significance was examined by paired t-test, *<em>p</em> &lt; 0.05 versus Control.</p></figcaption></figure></section><section id="s3-4"><h3 class="pmc_sec_title">Drug Effects on I<sub>Kr</sub> Window Currents in hiPSC-CMs</h3>
<p>Since the shift of activation or inactivation curves may change the window current, we assessed the I<sub>Kr</sub> window current in the same cells in absence and presence of a drug. Quinidine, ivabradine, ajmaline and mexiletine reduced the I<sub>Kr</sub> window current, but amiodarone, flecainide and ranolazine failed to do so in SQTS1-hiPSC-CMs (<a href="#F6" class="usa-link">Figures 6A–G</a>). In donor cells, quinidine, ajmaline and mexiletine also reduced the window current, whereas ivabradine, ranolazine, amiodarone and flecainide showed no effects (<a href="#F6" class="usa-link">Figures 6 H–N</a>) (<a href="#T1" class="usa-link">Table 1</a>).</p>
<figure class="fig xbox font-sm" id="F6"><h4 class="obj_head">FIGURE 6.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8138577_fphar-12-675003-g006.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e0/8138577/335e6d4ac844/fphar-12-675003-g006.jpg" loading="lazy" height="577" width="708" alt="FIGURE 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/F6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Drug effects on window currents of I<sub>Kr</sub> in SQTS1-hiPSC-CMs. The activation and inactivation curves were plotted in the same figure. The window current was defined as the current under the crossover of activation and inactivation curves. The activation curves are the same curves as in <a href="#F3" class="usa-link">Figure 3</a>. To obtain the inactivation curves, a pulse of 1 s from −80 to +60 mV was applied to activate and inactivate hERG channels. Then, the pulse was set to −100 mV for 20 ms to let the inactivated channels recover to open state. Before the deactivation occurs, a test pulse to +60 mV for 500 ms was applied and the peak current at the test potential was measured. The voltage of recovery pulses was changed from −100 to +80 mV. The currents at test pulse versus respective voltages of the recovery pulses were normalized to the maximal current and plotted against voltages of the recovery pulses to obtain the inactivation curves (availability-voltage curves). The cell numbers of activation curves are same as that in <a href="#F3" class="usa-link">Figure 3</a>. The cells numbers of inactivation curves are nine for each drug experiments. For comparison, the window currents in absence (black points and lines) and presence (grey points and lines) of drugs were overlapped in the same plot. <strong>(A–G)</strong> Overlapped activation and inactivation curves showing the widow currents in SQT1-hiPSC-CMs in absence (Ctr) and presence of quinidine (Qui, 10 µM), ajmaline (Ajm, 30 µM), amiodarone (Ami, 10 µM), ivabradine (Iva, 10 µM), flecainide (Fle, 30 µM), mexiletine (Mex, 100 µM) and ranolazine (Ran, 30 µM). <strong>(H–N)</strong> Overlapped activation and inactivation curves showing the widow currents in donor-hiPSC-CMs in absence (Ctr) and presence of each drug.</p></figcaption></figure></section><section id="s3-5"><h3 class="pmc_sec_title">Drug Effects on Recovery From Inactivation of I<sub>Kr</sub> in hiPSC-CMs</h3>
<p>To examine drug effect on the recovery of hERG channel from inactivation, the time constant (τ) of tail currents representing recovery of hERG channels from inactivation was analyzed (<a href="#F7" class="usa-link">Figures 7E,F</a>) (<a href="#T1" class="usa-link">Table 1</a>). In SQTS1-hiPSC-CMs, ajmaline, amiodarone and mexiletine speeded up the recovery, whereas flecainide and quinidine slowed it down. Ivabradine and ranolazine showed no significant effect (<a href="#F7" class="usa-link">Figure 7E</a>). In donor cells, the recovery speed was reduced by quinidine (<a href="#F7" class="usa-link">Figures 7B,F</a>), ivabradine and ranolazine, increased by amiodarone but not significantly affected by ajmaline, flecainide and mexiletine (<a href="#F7" class="usa-link">Figure 7F</a>). <a href="#F7" class="usa-link">Figures 7A,D</a> show examples of current recovery from inactivation in absence and presence of a drug (quinidine).</p>
<figure class="fig xbox font-sm" id="F7"><h4 class="obj_head">FIGURE 7.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8138577_fphar-12-675003-g007.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e0/8138577/fbec3da92346/fphar-12-675003-g007.jpg" loading="lazy" height="549" width="708" alt="FIGURE 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/F7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Drug effects on time constants of I<sub>Kr</sub> recovery from inactivation and deactivation in SQTS1-hiPSC-CMs. I<sub>Kr</sub> was evoked by a 1 s-long pre-pulse from −80 to 60 mV to let hERG channels be activated and some of them to be inactivated. The pre-pulse was followed by 500 ms test-pulses from −20 to −100 mV (10 mV increments). The protocol is shown in <strong>(B)</strong> (inset). Currents evoked by test pulses (tail currents) were used for analyzing the recovery from inactivation or deactivation of the currents. When the tail current increased, i.e., “b” is larger (more negative) than “a”, the current was defined as recovered current. The curves were fitted by single exponential decay to obtain time constants of recovery from inactivation. From −50 to −100 mV, deactivation became obvious. i.e., the current decrease again (the current at “d” is smaller than that at “c”. The change point “b/c” is defined as the end of recovered current and the start of the deactivation. <strong>(A)</strong> Representative traces of I<sub>Kr</sub> evoked by test pulses from −20 to −100 mV in absence (Control) and presence of 10 µM quinidine (Qui) in a donor-hiPSC-CM. <strong>(B)</strong> Mean values of time constants (τ) of I<sub>Kr</sub> recovery from inactivation at different voltages in donor-hiPSC-CMs in absence (Ctr) and presence of quinidine. <strong>(C)</strong> Mean values of time constants (τ) of I<sub>Kr</sub> deactivation at different voltages in donor-hiPSC-CMs in absence (Ctr) and presence of quinidine. <strong>(D)</strong> Representative traces of I<sub>Kr</sub> at −60 mV taken as recovered currents from inactivation in absence (Control) and presence of 10 µM quinidine (Qui) in donor-hiPSC-CMs. <strong>(E)</strong> Mean values of time constants (τ) of I<sub>Kr</sub> recovery from inactivation at −60 mV in SQT1-hiPSC-CMs in absence (Ctr) and presence of quinidine (Qui, 10 µM), ajmaline (Ajm, 30 µM), amiodarone (Ami, 10 µM), ivabradine (Iva, 10 µM), flecainide (Fle, 30 µM), mexiletine (Mex, 100 µM) and ranolazine (Ran, 30 µM). <strong>(F)</strong> Mean values of time constants (τ) of I<sub>Kr</sub> recovery from inactivation at −60 mV in donor-hiPSC-CMs in absence (Ctr) and presence of each drug. <strong>(G)</strong> Representative traces of I<sub>Kr</sub> at −80 mV taken as deactivated currents in absence (Control) and presence of 10 µM quinidine (Qui) in a donor-hiPSC-CM. <strong>(H)</strong> Mean values of time constants (τ) of I<sub>Kr</sub> deactivation at −80 mV in SQT1-hiPSC-CMs in absence (Ctr) and presence of quinidine (Qui, 10 µM), ajmaline (Ajm, 30 µM), amiodarone (Ami, 10 µM), ivabradine (Iva, 10 µM), flecainide (Fle, 30 µM), mexiletine (Mex, 100 µM) and ranolazine (Ran, 30 µM). <strong>(I)</strong> Mean values of time constants (τ) of I<sub>Kr</sub> deactivation at −80 mV in donor-hiPSC-CMs in absence (Ctr) and presence of each drug. Shown are mean ± SEM, n represents number of cells. The n-numbers given in <strong>(F)</strong> are also for <strong>(E)</strong>, <strong>(H)</strong> and <strong>(I)</strong>. The statistical significance was examined by paired t-test, *<em>p</em> &lt; 0.05 <em>vs.</em> Control.</p></figcaption></figure></section><section id="s3-6"><h3 class="pmc_sec_title">Drug Effects on Deactivation of I<sub>Kr</sub> in hiPSC-CMs</h3>
<p>Finally, the deactivation of I<sub>Kr</sub> was analyzed in hiPSC-CMs (<a href="#T1" class="usa-link">Table 1</a>, <a href="#F7" class="usa-link">Figures 7A,G–I</a>). In SQT1-hiPSC-CMs, quinidine, ajmaline, ivabradine and mexiletine reduced the speed of deactivation of hERG channels (the time constant τ was increased), but amiodarone, flecainide and ranolazine failed to change it (<a href="#F7" class="usa-link">Figure 7H</a>). In donor cells, amiodarone accelerated the deactivation (<a href="#F7" class="usa-link">Figure 7I</a>), while quinidine (<a href="#F7" class="usa-link">Figures 7C,I</a>), ivabradine and mexiletine decelerated it (<a href="#F7" class="usa-link">Figure 7I</a>). Ajmaline, flecainide and ranolazine did not influence the channel deactivation (<a href="#F7" class="usa-link">Figure 7I</a>). <a href="#F7" class="usa-link">Figures 7A,G</a> show examples of current deactivation in absence and presence of a drug (quinidine).</p></section></section><section id="s4"><h2 class="pmc_sec_title">Discussion</h2>
<p>In this study, we investigated the effects of quinidine, ajmaline, amiodarone, ivabradine, flecainide, mexiletine and ranolazine on gating kinetics of hERG channels in hiPSC-CMs from a SQT1-patient with N588k mutation. The study demonstrated that 1) these drugs affected differentially the hERG channel gating kinetics in donor- and SQT1-hiPSC-CMs, 2) quinidine, ajmaline, ivabradine and mexiletine reduced the window current of hERG channels and 3) quinidine, ajmaline, ivabradine and mexiletine decelerated deactivation of hERG channels. The latter two may be important for their antiarrhythmic effects previously observed in SQTS-patients (reduction of the occurrence of life-threatening arrhythmic events) or SQTS-hiPSC-CMs (reduction of epinephrine-induced arrhythmic events) (<a href="#B42" class="usa-link" aria-describedby="B42">Mazzanti et al., 2017</a>; <a href="#B84" class="usa-link" aria-describedby="B84">Zhao et al., 2019</a>).</p>
<p>In our previous study, we generated hiPSC-CMs from a patient with STQS1 carrying the hERG (KCNH2) gene mutation of N588K and characterized the phenotypic features (APD-shortening and arrhythmic events) (<a href="#B17" class="usa-link" aria-describedby="B17">El-Battrawy et al., 2018</a>). Using the cellular model of SQT1 (SQT1-hiPSC-CMs) we tested the APD-prolonging and antiarrhythmic effect of different drugs (<a href="#B17" class="usa-link" aria-describedby="B17">El-Battrawy et al., 2018</a>; <a href="#B84" class="usa-link" aria-describedby="B84">Zhao et al., 2019</a>; <a href="#B39" class="usa-link" aria-describedby="B39">Lan et al., 2020</a>). We have demonstrated that the SQTS1-hiPSC-CMs displayed shortened APD and increased arrhythmic events. Quinidine, disopyramide, ajmaline, ivabradine and mexiletine but not amiodarone, flecainide or ranolazine prolonged APD and reduced the arrhythmic episodes in SQT1-hiPSC-CMs (<a href="#B17" class="usa-link" aria-describedby="B17">El-Battrawy et al., 2018</a>; <a href="#B84" class="usa-link" aria-describedby="B84">Zhao et al., 2019</a>; <a href="#B39" class="usa-link" aria-describedby="B39">Lan et al., 2020</a>). Although we found that the inhibition of the N588K-hERG channel current by drugs is different, whether these drugs exert also different effects on N588K-hERG channel gating kinetics, which may help clarify the effect difference of drugs, is so far unknown. The current study was designed to address this open question and look for hints for selecting possible effective drugs for SQT1-treatment.</p>
<p>Quinidine is a multiple channel blocker with a high affinity to hERG and was a frequently used antiarrhythmic drug. It can inhibit I<sub>Na</sub> (Na channel current), I<sub>Ca-L</sub> (L-type Ca current), I<sub>to</sub> (transient outward K current), I<sub>Kr</sub> (hERG channel current), I<sub>Ks</sub> (slowly activating delayed rectifier K current), I<sub>K1</sub> (inward rectifier K current) and I<sub>KATP</sub> (ATP-sensitive-K channel current) (<a href="#s11" class="usa-link">Supplementary Table 1</a>) (<a href="#B55" class="usa-link" aria-describedby="B55">Pugsley et al., 2005</a>; <a href="#B46" class="usa-link" aria-describedby="B46">Michel et al., 2002</a>; <a href="#B52" class="usa-link" aria-describedby="B52">Paul et al., 2002</a>; <a href="#B77" class="usa-link" aria-describedby="B77">Yang et al., 2009</a>; <a href="#B32" class="usa-link" aria-describedby="B32">Imaizumi and Giles, 1987</a>; <a href="#B37" class="usa-link" aria-describedby="B37">Koepple et al., 2017</a>; <a href="#B70" class="usa-link" aria-describedby="B70">Undrovinas et al., 1990</a>). The I<sub>Na</sub>-inhibiting effect can reduce the speed of depolarization and excitation conduction, and hence reduce occurrence of some arrhythmias. The inhibition of I<sub>Ca-L</sub> may shorten APD, whereas the inhibition of K currents can prolong APD. In fact, quinidine prolongs APD in wild-type (healthy) and SQTS-cells (<a href="#T1" class="usa-link">Table 1</a>) (<a href="#B14" class="usa-link" aria-describedby="B14">Davidenko et al., 1989</a>; <a href="#B29" class="usa-link" aria-describedby="B29">Guo et al., 2019</a>), indicating that its effect on K currents is larger than that on I<sub>Ca-L</sub>. The APD-prolonging effect can be antiarrhythmic and also proarrhythmic. Quinidine was clinically used as an antiarrhythmic drug, but the severe side effects of quinidine reduced its clinical relevance for arrhythmia-treatment. However, when it was shown to be effective for SQT-patients, it absorbed again interests of physicians and researchers. It was found that although the mutation N588K in hERG channel rendered hERG channel resistant to many drugs including typical hERG channel blockers, the channel remains still sensitive to quinidine. One reason for the efficacy of quinidine is that quinidine affects hERG channels in both open and closed (inactivated) state, different from other drugs that affect only or mainly inactivated hERG channels. The N588K mutation reduced the inactivation of hERG channel and hence reduced the effects of inactivation-affecting drugs like E-4031, sotalol, dofetilide and terfenadine (<a href="#B43" class="usa-link" aria-describedby="B43">McPate et al., 2008</a>; <a href="#B53" class="usa-link" aria-describedby="B53">Perrin et al., 2008</a>). Quinidine effect is only partially changed by N588K mutation because its open-channel-affecting effect is not influenced by the mutation. Therefore, quinidine is effective for SQT-patients with N588K mutation and recommended for application in SQT-patients (<a href="#B54" class="usa-link" aria-describedby="B54">Priori et al., 2015</a>). Since previously reported studies focused on the change of channel sensitivity (shift of dose-response curve) induced by N588K-mutation, the influence of N588K on drug effects regarding the hERG channel gating kinetic parameters was not analyzed in detail. In the current study, we found out that the quinidine effects on the time to peak and activation curve, on the time constant of inactivation and inactivation curve, on the time constants of recovery from inactivation and the deactivation as well as on the window current of the hERG channel were similar in donor- and SQT1-hiPSC-CMs, suggesting that quinidine effects on hERG channel gating are not severely changed by N588K.</p>
<p>The class Ia anti-arrhythmic drug ajmaline is frequently applied to induce phenotypic changes of Brugada syndrome (BrS) in ECG for diagnostic aim. Studies reported that ajmaline inhibits various currents, including I<sub>Na</sub>, I<sub>Ca-L</sub>, I<sub>to</sub>, I<sub>Kr</sub>, I<sub>K1</sub> and I<sub>KATP</sub> (<a href="#s11" class="usa-link">Supplementary Table 1</a>) (<a href="#B48" class="usa-link" aria-describedby="B48">Miller et al., 2017</a>; <a href="#B5" class="usa-link" aria-describedby="B5">Bébarová et al., 2005a</a>; <a href="#B35" class="usa-link" aria-describedby="B35">Khodorov and Zaborovskaya, 1983</a>; <a href="#B6" class="usa-link" aria-describedby="B6">Bébarová et al., 2005b</a>; <a href="#B36" class="usa-link" aria-describedby="B36">Kiesecker et al., 2004</a>). The inhibition of I<sub>to</sub>, I<sub>Kr</sub>, I<sub>K1</sub> and I<sub>KATP</sub> can prolong APD and hence APD-prolongation induced by ajmaline was observed in both wild-type cells and an SQT-model (<a href="#T1" class="usa-link">Table 1</a>) (<a href="#B6" class="usa-link" aria-describedby="B6">Bébarová et al., 2005b</a>; <a href="#B34" class="usa-link" aria-describedby="B34">Jæger et al., 2021</a>). This led us to assume that it may inhibit the hERG channel current in SQTS1-hiPSC-CMs. Indeed, ajmaline inhibited the hERG channel current, prolonged APD and reduced arrhythmic events in SQTS1-cells (<a href="#B84" class="usa-link" aria-describedby="B84">Zhao et al., 2019</a>). In HEK cells and Xenopus oocytes expressing hERG channels, ajmaline inhibited the hERG current and the Y652A and F656A mutations abolished the ajmaline effect (<a href="#B36" class="usa-link" aria-describedby="B36">Kiesecker et al., 2004</a>). Ajmaline shifted slightly the half-maximal activation voltage toward more negative potentials but did not significantly influence hERG inactivation curve, although it reduced the τ value of inactivation (<a href="#B36" class="usa-link" aria-describedby="B36">Kiesecker et al., 2004</a>). The influence of N588K on ajmaline effects was not examined in that study. Here in the current study, we add novel data about ajmaline effects on the gating parameters of wild-type and N588K-hERG channels in hiPSC-CMs. The effects of ajmaline on hERG channel current data including the time to peak, τ of inactivation, activation and inactivation curves and the window current are similar (changes in the same direction) in donor- and SQT1-hiPSC-CMs, while its effects on the time constants of recovery from inactivation and deactivation were observed only in SQT1-hiPSC-CMs. These data may be helpful for understanding the anti- or pro-arrhythmic feature of the drug. Since ajmaline can inhibit other ion channel currents, its inhibitory effect on I<sub>to</sub>, I<sub>K1</sub> and I<sub>KATP</sub> may also contribute its APD-prolonging and antiarrhythmic effects in SQTS.</p>
<p>Amiodarone alone showed no QTc-prolonging effect, but amiodarone together with metoprolol prolonged QTc in a SQTS-patient (<a href="#B27" class="usa-link" aria-describedby="B27">Giustetto et al., 2011</a>). The benefit of amiodarone for SQTS-patients is still questionable. In our hiPS-CMs from the patient with SQTS1, amiodarone failed to prolong APD and to reduce arrhythmic events. Amiodarone is similar to quinidine in inhibiting hERG current conducted by the mutant (N588K) hERG channel (<a href="#B43" class="usa-link" aria-describedby="B43">McPate et al., 2008</a>). Since the influence of N588K on amiodarone effects regarding gating kinetics of hERG channels was not investigated, it is difficult to understand why quinidine but not amiodarone is effective in SQT1-patients. Our current study detected the difference, i.e., quinidine reduced the window current, decelerated the recovery from inactivation and deactivation, while amiodarone showed no or opposite effects on those parameters. Besides hERG current, I<sub>Na</sub>, I<sub>Ca-L</sub>, I<sub>NCX</sub>, I<sub>to</sub>, I<sub>Ks</sub>, I<sub>K1</sub> and I<sub>KATP</sub> can be inhibited by amiodarone (<a href="#s11" class="usa-link">Supplementary Table 1</a>) (<a href="#B51" class="usa-link" aria-describedby="B51">Nishida et al., 2011</a>; <a href="#B67" class="usa-link" aria-describedby="B67">Suzuki et al., 2013</a>; <a href="#B33" class="usa-link" aria-describedby="B33">Iwamoto et al., 2007</a>; <a href="#B75" class="usa-link" aria-describedby="B75">Watanabe, 2019</a>). The inhibition of I<sub>Ca-L</sub> may shorten APD, while the inhibition of I<sub>to</sub>, I<sub>Ks</sub>, I<sub>K1</sub> and I<sub>KATP</sub> can prolong APD. In wild-type cells, amiodarone prolonged or showed no effect on APD (<a href="#T1" class="usa-link">Table 1</a>) (<a href="#B4" class="usa-link" aria-describedby="B4">Aomine, 1988</a>; <a href="#B61" class="usa-link" aria-describedby="B61">Sasaki et al., 2014</a>). In our experiments, amiodarone failed to changed APD significantly, implying that its effects on inward currents and outward currents are similar.</p>
<p>Ivabradine could prolong QT interval and suppress the arrhythmic events in rabbit models of SQTS induced by an ATP-sensitive potassium channel activator pinacidil (<a href="#B24" class="usa-link" aria-describedby="B24">Frommeyer et al., 2017</a>). Ivabradine is a well-known funny channel (I<sub>f</sub>) blocker. Since it displayed no negative inotropic effects and is useful to maintain stable hemodynamics, it is clinically administered to reduce heart rate in patients with heart failure. Ivabradine also inhibits hERG channel currents (<a href="#B40" class="usa-link" aria-describedby="B40">Lees-Miller et al., 2015</a>). In a study, hERG channels, either WT or mutated, were expressed by transfection into HEK393 cells and ivabradine effects on the channels were investigated (<a href="#B44" class="usa-link" aria-describedby="B44">Melgari et al., 2015</a>). In that study, Melgari et al. demonstrated that ivabradine inhibited the WT- and mutated hERG channel current. N588K and S624A variants slightly reduced ivabradine effect, while Y652A and F656A strongly reduced its effect. In addition, the authors also showed that ivabradine shifted both the activation and inactivation curve to a more negative potential without effect on the speed (τ) of inactivation of the WT-hERG channel. In the current study, we demonstrated that the inhibition of hERG current by ivabradine was reduced and the inactivation curve was shifted to a more negative potential, consistent with the previous study. However, we found that ivabradine shifted the activation curve to a more positive potential, which differs from the results of the Melgari study. Moreover, we observed that ivabradine prolonged the time to peak, reduced the time constant of inactivation and increased the time constant of deactivation in both donor and SQT1-cells, reduced the window current in SQT1-cells but not in donor-cells, and increased the time constant of recovery in donor-cells but not in SQT1-cells. These data are new because previous studies including Melgari study did not investigate ivabradine effects on these parameters in N588K-hERG channels or in SQT1-cells. Besides hERG current, I<sub>Na</sub>, but not I<sub>Ca-L</sub>, I<sub>Ks</sub> and I<sub>K1</sub> can be inhibited by ivabradine (<a href="#s11" class="usa-link">Supplementary Table 1</a>) (<a href="#B31" class="usa-link" aria-describedby="B31">Haechl et al., 2019</a>; <a href="#B15" class="usa-link" aria-describedby="B15">Demontis et al., 2009</a>). The inhibition of I<sub>Na</sub> may contribute to antiarrhythmic but not APD-prolonging effect. In previous studies, ivabradine showed no effect or prolonging or shortening effect on APD in wild type cells (<a href="#T1" class="usa-link">Table 1</a>) (<a href="#B38" class="usa-link" aria-describedby="B38">Koncz et al., 2011</a>; <a href="#B31" class="usa-link" aria-describedby="B31">Haechl et al., 2019</a>). It seems that ivabradine effect on APD mainly resulted from its effect on I<sub>Kr</sub>.</p>
<p>Mexiletine, a sodium channel blocker, was shown to be effective for suppressing arrhythmias in a rabbit model of SQTS and atrial fibrillation (AF) (<a href="#B25" class="usa-link" aria-describedby="B25">Frommeyer et al., 2018</a>). In our recent study, using the SQT1-hiPSC-CMs we also observed profitable results of mexiletine, prolonging APD and reducing arrhythmic events. Although mexiletine inhibited I<sub>Kr</sub> in SQTS1-hiPSC-CMs, its effect on I<sub>Kr</sub> gating kinetic parameter has not been assessed. In a previous study from Gualdani et al., WT and mutant hERG channels were expressed in HEK293 or CHO cells and mexiletine effects were assessed (<a href="#B28" class="usa-link" aria-describedby="B28">Gualdani et al., 2015</a>). The study demonstrated that i) Mexiletine inhibited the hERG channel current in a time- and voltage-dependent way; ii) Its inhibitory effect was strongly reduced by Y652A and F656A mutants; iii) It reduced the time constant of activation but increased the time constant of deactivation, meaning that it accelerated activation and decelerated deactivation; iv) Mexiletine did not influence the channel inactivation. The effects of mexiletine on gating kinetics of N588K-hERG channels were not investigated. Our current study detected that the inhibitory effect of mexiletine was strongly reduced in SQT1-hiPSC-CMs carrying the N588K mutation. Mexiletine reduced the time to peak in both donor and SQT1-cells, suggesting an increase in activation speed, consistent with the Gualdani study. In our study, mexiletine increased the time constant of deactivation (consistent with the previous study) but reduced the time constant of inactivation (different from the previous study) in both donor and SQT1-cells. The differences between our and the previous study may result from using different cell types. Further, mexiletine reduced the time constant of recovery from inactivation and the window current as well, which have not been shown before. In addition, mexiletine can inhibit I<sub>Na</sub>, I<sub>Ca-L</sub>, I<sub>NCX</sub>, I<sub>Ks</sub> and I<sub>to,</sub> and activate I<sub>KATP</sub> (<a href="#s11" class="usa-link">Supplementary Table 1</a>) (<a href="#B72" class="usa-link" aria-describedby="B72">Wang et al., 1996</a>; <a href="#B78" class="usa-link" aria-describedby="B78">Yonemizu et al., 2019</a>; <a href="#B57" class="usa-link" aria-describedby="B57">Rahm et al., 2020</a>; <a href="#B49" class="usa-link" aria-describedby="B49">Mitcheson and Hancox, 1997</a>). The I<sub>Ca-L</sub>-inhibiting and I<sub>KATP</sub>-activation can explain the APD-shortening effect of mexiletine in wild-type cardiomyocytes (<a href="#T1" class="usa-link">Table 1</a>) (<a href="#B41" class="usa-link" aria-describedby="B41">Matsuo et al., 1985</a>; <a href="#B62" class="usa-link" aria-describedby="B62">Sato et al., 1995</a>). The I<sub>Kr</sub>-, I<sub>Ks</sub>- and I<sub>to</sub>-inhibiting effects can be the reason for APD-prolonging effect observed in SQT-cells (<a href="#B25" class="usa-link" aria-describedby="B25">Frommeyer et al., 2018</a>). Whether mexiletine prolongs or shortens APD in cells, probably depends on its net effect on the inward and outward currents. In our hiPSC-CMs, mexiletine prolonged APD, suggesting that its effect on outward current is predominant.</p>
<p>Flecainide has been shown to prolong APD and refractory period but did not reduce the rate of inducibility of ventricular fibrillation in a rabbit model of SQTS (<a href="#B47" class="usa-link" aria-describedby="B47">Milberg et al., 2007</a>). In a clinical study, it was shown to be ineffective for prolonging QT interval and reducing arrhythmias (<a href="#B26" class="usa-link" aria-describedby="B26">Gaita et al., 2004</a>). In our recent study, it inhibited slightly the hERG channel current, but failed to prolong APD or to reduce arrhythmic events in SQT1-hiPSC-CMs (<a href="#B84" class="usa-link" aria-describedby="B84">Zhao et al., 2019</a>). Before, it was shown that flecainide inhibited hERG channel currents in HEK cells and N588K reduced flecainide effect (<a href="#B45" class="usa-link" aria-describedby="B45">Melgari et al., 2015</a>). Flecainide did not influence the voltage-dependent inactivation curve but increased the time constant of inactivation of wild-type hERG channels (<a href="#B45" class="usa-link" aria-describedby="B45">Melgari et al., 2015</a>). Flecainide shifted activation curve to a more negative potential but did not influence the time constant of deactivation of wild-type hERG channels (<a href="#B52" class="usa-link" aria-describedby="B52">Paul et al., 2002</a>). Flecainide effects on gating kinetics of N588K-hERG channel have not been reported. Our current study showed that i) The inhibitory effect of flecainide was largely reduced in SQT1-cells, ii) The time to peak of hERG current was prolonged in donor but not in SQT1-cells and iii) The inactivation curve was shifted to a more negative potential in donor but not in SQT1-cells. The latter may help us understand the reduced inhibitory effect of flecainide in SQT1-hiPSC-CMs. Flecainide did not change the window current of hERG channels. It decelerated the recovery from inactivation in SQT1-hiPSC-CMs and showed no effect on the channel deactivation. These data may help explain why flecainide showed no antiarrhythmic effects in SQT1-hiPSC-CMs and SQT-patients because these effects are different from that of quinidine, ajmaline, ivabradine and mexiletine, which prolonged APD and reduced epinephrine-induced arrhythmic events in SQT1-hiPSC-CMs. Flecainide can inhibit I<sub>Na</sub>, I<sub>Ca-L</sub>, I<sub>to</sub>, I<sub>KATP</sub>, and enhance I<sub>NCX</sub> and I<sub>K1</sub> but has no effect on I<sub>Ks</sub> (<a href="#s11" class="usa-link">Supplementary Table 1</a>) (<a href="#B75" class="usa-link" aria-describedby="B75">Watanabe, 2019</a>; <a href="#B72" class="usa-link" aria-describedby="B72">Wang et al., 1996</a>; <a href="#B71" class="usa-link" aria-describedby="B71">Wang et al., 1993</a>; <a href="#B21" class="usa-link" aria-describedby="B21">Follmer and Colatsky, 1990</a>; <a href="#B10" class="usa-link" aria-describedby="B10">Caballero et al., 2010</a>; <a href="#B80" class="usa-link" aria-describedby="B80">Yunoki et al., 2001</a>). The inhibition of I<sub>to</sub> and I<sub>KATP</sub> can prolong APD, which may contribute to the APD-prolongation observed in healthy cardiomyocytes (<a href="#T1" class="usa-link">Table 1</a>) (<a href="#B8" class="usa-link" aria-describedby="B8">Borchard and Boisten, 1982</a>; <a href="#B71" class="usa-link" aria-describedby="B71">Wang et al., 1993</a>). In the current study, we did not examine the effect of flecainide on these currents. The fact that flecainide failed to prolong APD in SQT1-hiPSC-CMs suggests that its effect on I<sub>to</sub> and I<sub>KATP</sub> is probably also attenuated in SQT1-cells.</p>
<p>Ranolazine, an antianginal drug, possesses also antiarrhythmic effects (<a href="#B22" class="usa-link" aria-describedby="B22">Frommeyer et al., 2012</a>; <a href="#B9" class="usa-link" aria-describedby="B9">Burashnikov et al., 2012</a>). It showed potent antiarrhythmic properties in the rabbit model of pinacidil-induced SQTS (<a href="#B23" class="usa-link" aria-describedby="B23">Frommeyer et al., 2016</a>). Ranolazine was shown to block I<sub>Kr</sub> in dog cardiomyocytes (<a href="#B2" class="usa-link" aria-describedby="B2">Antzelevitch et al., 2004a</a>; <a href="#B64" class="usa-link" aria-describedby="B64">Schram et al., 2004</a>). In HEK cells expressing WT- and mutant hERG channels, ranolazine inhibited the hERG channel current and its effect was reduced by different mutants including N588K<sup>69</sup>. It shifted the activation curve of WT hERG channels to a more negative potential (<a href="#B16" class="usa-link" aria-describedby="B16">Du et al., 2014</a>; <a href="#B58" class="usa-link" aria-describedby="B58">Rajamani et al., 2008</a>). It was also shown that ranolazine reduced the time constant of inactivation and showed no effect on the time constant of recovery from inactivation of hERG channels in HEK cells (<a href="#B58" class="usa-link" aria-describedby="B58">Rajamani et al., 2008</a>). Effects of ranolazine on gating kinetic parameters of mutant hERG channels have not been shown. Our study analyzed in detail the effects of ranolazine on the activation, inactivation, recovery from inactivation and deactivation of hERG channel currents in both healthy donor and SQT1-hiPSC-CMs. The main findings are that both the activation and inactivation curves were shifted in the same direction and hence the window current was not changed. The time to peak and time constant of deactivation were similar in donor and SQT1-hiPSC-CMs. The time constant of inactivation and time constant of recovery from inactivation were differentially affected by ranolazine in donor- and SQT1-hiPSC-CMs. Besides hERG current, ranolazine can inhibit I<sub>Na</sub>, I<sub>Ca-L</sub>, I<sub>NCX</sub>, I<sub>to</sub> and I<sub>Ks</sub> without effect onI<sub>K1</sub> (<a href="#s11" class="usa-link">Supplementary Table 1</a>) (<a href="#B3" class="usa-link" aria-describedby="B3">Antzelevitch et al., 2004b</a>; <a href="#B56" class="usa-link" aria-describedby="B56">Qian et al., 2012</a>). Action potential prolongation and shortening induced by ranolazine were observed in wild-type cells (<a href="#T1" class="usa-link">Table 1</a>) (<a href="#B2" class="usa-link" aria-describedby="B2">Antzelevitch et al., 2004a</a>; <a href="#B76" class="usa-link" aria-describedby="B76">Wu et al., 2004</a>; <a href="#B23" class="usa-link" aria-describedby="B23">Frommeyer et al., 2016</a>). The inhibition of I<sub>Ca-L</sub> can shorten APD, while inhibition of I<sub>Kr</sub> and I<sub>Ks</sub> can explain the APD-prolongation. In our SQT1-hiPSC-CMs, ranolazine did not prolong APD, probably, its effect on I<sub>Ks</sub> was also attenuated or its inhibitory effect on I<sub>Ca-L</sub> was enhanced, which counteracted the APD-prolonging effect of inhibition of I<sub>Kr</sub> and I<sub>Ks</sub>.</p>
<p>Taking all the data together, all the examined drugs inhibited the hERG channel current in both donor- and SQT1-hiPSC-CMs. The inhibition by each drug was reduced in SQT1-cells. Though the tested drugs displayed some differences regarding effects on the hERG channel gating kinetics in donor or SQT1-hiPSC-CMs, we observed important features, i.e., 1) quinidine, ajmaline, ivabradine and mexiletine but not amiodarone, flecainide and ranolazine reduced the window current in SQT1-hiPSC-CMs, 2) quinidine, ajmaline, ivabradine and mexiletine but not amiodarone, flecainide and ranolazine increased the time constant of deactivation (the speed of deactivation was reduced). Since quinidine, ajmaline, ivabradine and mexiletine but not amiodarone, flecainide and ranolazine showed APD-prolonging and antiarrhythmic effects in SQT1-hiPSC-CMs (<a href="#B84" class="usa-link" aria-describedby="B84">Zhao et al., 2019</a>), we assume that the window current-reducing and deactivation-slowing effect may be important for antiarrhythmic effects of drugs in SQT1-paptient with hERG mutation, at least with a N588K mutation.</p>
<p>Notably, all the seven drugs tested in this study have effects on multiple ion channels (<a href="#s11" class="usa-link">Supplementary Table 1</a>). Theoretically, either an enhancement of inward current or a suppression of outward current or both can prolong APD/QTc. Therefore, the effects of quinidine, ajmaline, ivabradine and mexiletine on ion channel currents other than I<sub>Kr</sub> may also contribute to their APD/QTc-prolonging and antiarrhythmic effects.</p>
<p>The concentrations of drugs used in the study were higher than that used in patients. The concentrations were selected because they showed noticeable effects (either on I<sub>Kr</sub> or APD or arrhythmic events) in hiPSC-CMs. The reason for requirement of higher concentration is not clear. Probably, the sensitivity of cells to drugs is reduced due to challenges in cell splitting, single cell isolation or unphysiological cell culture. The high concentration may enhance the toxicity or side effects of a drug and limit the drug application in patients. Besides, cells in other systems express also hERG channels, which may be also inhibited when the drug is used in a SQTS-patient. This may further limit the application of hERG-inhibiting drugs in patients. Therefore, the data from our study cannot be directly translated to clinical use, instead, provide information for designing clinical studies. On the other hand, it is possible that in patients lower concentrations of drugs are required to exert effects same with or similar to that observed in our study. Our hiPSC-CM platform for drug testing can provide possible candidate drugs, but the real efficacy and safe concentrations in patients need to be examined in clinical studies<strong>.</strong>
</p>
<p>In summary, we analyzed effects of quinidine, ajmaline, amiodarone, ivabradine, flecainide, mexiletine and ranolazine on hERG channel gating kinetic parameters. We observed that all the tested drugs have some effects on hERG gating parameters in donor or SQT1-hiPSC-CMs (<a href="#T1" class="usa-link">Table 1</a>), but constant effects on hERG window current and deactivation were detected only in the application of quinidine, ajmaline, ivabradine and mexiletine, which may be one of the reasons for their effective antiarrhythmic effects in SQT1-cells.</p></section><section id="s5"><h2 class="pmc_sec_title">Conclusion</h2>
<p>From the results we conclude that the window current-reducing and deactivation-slowing effects may be important for the antiarrhythmic effects of drugs in SQT1-paptients with a hERG mutation, at least with a N588K mutation. These findings may help us to search for potential candidate drugs for treating SQT1-patients.</p></section><section id="s6"><h2 class="pmc_sec_title">Study Limitations</h2>
<p>We recruited only one SQT1-patient and one healthy donor for this study. Differences among individuals cannot be ruled out. Due to the hurdle to find more SQT1-patients with the same mutation, the study focused on cell line from single patient. Therefore, the study may be relevant for personalized medicine, e.g., for planning a therapeutical strategy for this specific SQT-hiPSC-CM donor.</p>
<p>Isogenic control cells were not used in the study. The possibility that the different gene background in heathy donor and SQT1 cells influenced the drug effects cannot be completely excluded.</p>
<p>Since the concentration of drugs used in the study was higher than that used in patients, possible drug toxicity <em>in vivo</em> needs to be considered when interpreting the data of the current study.</p>
<p>All the measurements were performed at room temperature. The possible influence of temperature on drug effects was not examined in this study. In previously reported studies with respect to hERG channel current or drug effect on the current, some were performed at room temperature (<a href="#B60" class="usa-link" aria-describedby="B60">Sanguinetti et al., 1995</a>; <a href="#B69" class="usa-link" aria-describedby="B69">Trudeau et al., 1995</a>; <a href="#B66" class="usa-link" aria-describedby="B66">Snyders and Chaudhary, 1996</a>; <a href="#B73" class="usa-link" aria-describedby="B73">Wang et al., 1997</a>; <a href="#B81" class="usa-link" aria-describedby="B81">Zhang et al., 1999</a>; <a href="#B36" class="usa-link" aria-describedby="B36">Kiesecker et al., 2004</a>; <a href="#B12" class="usa-link" aria-describedby="B12">Cordeiro et al., 2005</a>; <a href="#B58" class="usa-link" aria-describedby="B58">Rajamani et al., 2008</a>), some at physiological temperature (37°C) (<a href="#B52" class="usa-link" aria-describedby="B52">Paul et al., 2002</a>; <a href="#B43" class="usa-link" aria-describedby="B43">McPate et al., 2008</a>; <a href="#B44" class="usa-link" aria-describedby="B44">Melgari et al., 2015</a>; <a href="#B45" class="usa-link" aria-describedby="B45">Melgari et al., 2015</a>). It has been shown that hERG channel current is temperature-sensitive (<a href="#B85" class="usa-link" aria-describedby="B85">Zhou et al., 1998</a>; <a href="#B74" class="usa-link" aria-describedby="B74">Wang et al., 2003</a>). This may suggest a possible influence of temperature on drug effects. On the other hand, it is also possible that the temperature influence on drug effects is minor because the temperature-sensitivity of the channel does not mean the drug effect is also temperature-sensitive. The temperature may underestimate or overestimate (amplify) drug effects, but it is also possible that temperature does not change drug effect when temperature changes at certain range. Cs<sup>+</sup> instead of K<sup>+</sup> was used as the charge carrier for recording hERG current since Cs<sup>+</sup> can be conducted by hERG channel but not by other K<sup>+</sup> channels and hence can separate hERG channel current from other K<sup>+</sup> currents (<a href="#B63" class="usa-link" aria-describedby="B63">Schönherr and Heinemann, 1996</a>; <a href="#B79" class="usa-link" aria-describedby="B79">Youm et al., 2004</a>; <a href="#B83" class="usa-link" aria-describedby="B83">Zhang, 2006</a>). It was reported that Cs<sup>+</sup> can slow hERG channel inactivation but has no effect on the channel activation (<a href="#B82" class="usa-link" aria-describedby="B82">Zhang et al., 2003</a>). This suggests a possibility that Cs<sup>+</sup> may influence some drug effects. It is possible that Cs<sup>+</sup> may reduce or enhance drug effects, but it is also possible that it has no influence on some drug effects. Taken together, the drug effects shown in this study were detected under unphysiological conditions and therefore need to be examined in more physiological studies in future.</p>
<p>Another limitation may be the immaturity of hiPSC-CMs. The immature hiPSC-CMs possess similarities but also differences compared with adult human cardiomyocytes. As shown before, the expression profile of some ion channels in hiPSC-CMs may be different from that in adult cardiomyocytes and even more, hiPSC-CMs from different cell lines may also show different expression profile of ion channels (<a href="#B7" class="usa-link" aria-describedby="B7">Blinova et al., 2017</a>), which may influence drug effects in hiPSC-CMs. This should be taken into account when interpreting the data.</p>
<p>I<sub>NCX</sub> is known to have both an inward and an outward component at different phases of APs. Although we reported in <a href="#s11" class="usa-link">Supplementary Table 1</a> the drug effects on I<sub>NCX</sub>, it is not simple speculating on how its activation/inhibition could affect APD following drug administration. This would require a more detailed analysis that is out of the scope of this manuscript.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>We gratefully thank C. Liebetrau for excellent technical assistance. We thank the Chinese Scholarship Council (CSC) for the financial support for Mengying Huang, Zhihan Zhao, Xin Li and Xuehui Fan. Excellent technical support by the Stem Cell Unit Göttingen is acknowledged.</p></section><section id="s7"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>The original contributions presented in the study are included in the article/<a href="#s11" class="usa-link">Supplementary Material</a>, further inquiries can be directed to the corresponding author.</p></section><section id="s8"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>MH, XL, ZL, XF, ZY, YL and ZZ performed experiments. SL analyzed data. LC, MB, XZ, IA and IE designed the study and wrote the paper.</p></section><section id="s9"><h2 class="pmc_sec_title">Funding</h2>
<p>This study was supported by the Post-doc of German Center for Cardiovascular Research (DZHK) (81Z0500204) and shared expertise (81X2500208).</p></section><section id="s10"><h2 class="pmc_sec_title">Conflict of Interest</h2>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></section><section id="s11"><h2 class="pmc_sec_title">Supplementary Material</h2>
<p>The Supplementary Material for this article can be found online at: <a href="https://www.frontiersin.org/articles/10.3389/fphar.2021.675003/full#supplementary-material" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.frontiersin.org/articles/10.3389/fphar.2021.675003/full#supplementary-material</a>
</p>
<section class="sm xbox font-sm" id="SM1"><div class="media p"><div class="caption">
<a href="/articles/instance/8138577/bin/DataSheet1.pdf" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (186.4KB, pdf) </sup>
</div></div></section></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ol class="ref-list font-sm">
<li id="B1">
<cite>
Abriel H., Rougier J. S. (2013). β-Blockers in Congenital Short-QT Syndrome as Ion Channel Blockers. J. Cardiovasc. Electrophysiol.
24, 1172–1174. 10.1111/jce.12204
</cite> [<a href="https://doi.org/10.1111/jce.12204" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23890274/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Cardiovasc.%20Electrophysiol.&amp;title=%CE%B2-Blockers%20in%20Congenital%20Short-QT%20Syndrome%20as%20Ion%20Channel%20Blockers&amp;author=H.%20Abriel&amp;author=J.%20S.%20Rougier&amp;volume=24&amp;publication_year=2013&amp;pages=1172-1174&amp;pmid=23890274&amp;doi=10.1111/jce.12204&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2">
<cite>
Antzelevitch C., Belardinelli L., Wu L., Fraser H., Zygmunt A. C., Burashnikov A., et al.  (2004a). Electrophysiologic Properties and Antiarrhythmic Actions of a Novel Antianginal Agent. J. Cardiovasc. Pharmacol. Ther.
9 (Suppl. 1), S65–S83. 10.1177/107424840400900106
</cite> [<a href="https://doi.org/10.1177/107424840400900106" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15378132/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Cardiovasc.%20Pharmacol.%20Ther.&amp;title=Electrophysiologic%20Properties%20and%20Antiarrhythmic%20Actions%20of%20a%20Novel%20Antianginal%20Agent&amp;author=C.%20Antzelevitch&amp;author=L.%20Belardinelli&amp;author=L.%20Wu&amp;author=H.%20Fraser&amp;author=A.%20C.%20Zygmunt&amp;volume=9&amp;issue=Suppl.%201&amp;publication_year=2004a&amp;pages=S65-S83&amp;pmid=15378132&amp;doi=10.1177/107424840400900106&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3">
<cite>
Antzelevitch C., Belardinelli L., Zygmunt A. C., Burashnikov A., Di Diego J. M., Fish J. M., et al.  (2004b). Electrophysiological Effects of Ranolazine, a Novel Antianginal Agent with Antiarrhythmic Properties. Circulation
110, 904–910. 10.1161/01.cir.0000139333.83620.5d
</cite> [<a href="https://doi.org/10.1161/01.cir.0000139333.83620.5d" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1513623/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15302796/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Electrophysiological%20Effects%20of%20Ranolazine,%20a%20Novel%20Antianginal%20Agent%20with%20Antiarrhythmic%20Properties&amp;author=C.%20Antzelevitch&amp;author=L.%20Belardinelli&amp;author=A.%20C.%20Zygmunt&amp;author=A.%20Burashnikov&amp;author=J.%20M.%20Di%20Diego&amp;volume=110&amp;publication_year=2004b&amp;pages=904-910&amp;pmid=15302796&amp;doi=10.1161/01.cir.0000139333.83620.5d&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4">
<cite>
Aomine M. (1988). Does Acute Exposure to Amiodarone Prolong Cardiac Action Potential Duration?
Gen. Pharmacol. Vasc. Syst.
19, 615–619. 10.1016/0306-3623(88)90173-5
</cite> [<a href="https://doi.org/10.1016/0306-3623(88)90173-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3410284/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gen.%20Pharmacol.%20Vasc.%20Syst.&amp;title=Does%20Acute%20Exposure%20to%20Amiodarone%20Prolong%20Cardiac%20Action%20Potential%20Duration?&amp;author=M.%20Aomine&amp;volume=19&amp;publication_year=1988&amp;pages=615-619&amp;pmid=3410284&amp;doi=10.1016/0306-3623(88)90173-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B5">
<cite>
Bébarová M., Matejovic P., Pásek M., Simurdová M., Simurda J. (2005a). Effect of Ajmaline on Transient Outward Current in Rat Ventricular Myocytes. Gen. Physiol. Biophys.
24, 27–45. 10.1113/expphysiol.2004.029439
</cite> [<a href="https://doi.org/10.1113/expphysiol.2004.029439" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15900085/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gen.%20Physiol.%20Biophys.&amp;title=Effect%20of%20Ajmaline%20on%20Transient%20Outward%20Current%20in%20Rat%20Ventricular%20Myocytes&amp;author=M.%20B%C3%A9barov%C3%A1&amp;author=P.%20Matejovic&amp;author=M.%20P%C3%A1sek&amp;author=M.%20Simurdov%C3%A1&amp;author=J.%20Simurda&amp;volume=24&amp;publication_year=2005a&amp;pages=27-45&amp;pmid=15900085&amp;doi=10.1113/expphysiol.2004.029439&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6">
<cite>
Bébarová M., Matejovic P., Pásek M., Simurdová M., Simurda J. (2005b). Effect of Ajmaline on Action Potential and Ionic Currents in Rat Ventricular Myocytes. Gen. Physiol. Biophys.
24, 311–325. 10.1113/expphysiol.2005.031096
</cite> [<a href="https://doi.org/10.1113/expphysiol.2005.031096" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16308426/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gen.%20Physiol.%20Biophys.&amp;title=Effect%20of%20Ajmaline%20on%20Action%20Potential%20and%20Ionic%20Currents%20in%20Rat%20Ventricular%20Myocytes&amp;author=M.%20B%C3%A9barov%C3%A1&amp;author=P.%20Matejovic&amp;author=M.%20P%C3%A1sek&amp;author=M.%20Simurdov%C3%A1&amp;author=J.%20Simurda&amp;volume=24&amp;publication_year=2005b&amp;pages=311-325&amp;pmid=16308426&amp;doi=10.1113/expphysiol.2005.031096&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7">
<cite>
Blinova K., Stohlman J., Vicente J., Chan D., Johannesen L., Hortigon-Vinagre M. P., et al.  (2017). Comprehensive Translational Assessment of Human-Induced Pluripotent Stem Cell Derived Cardiomyocytes for Evaluating Drug-Induced Arrhythmias. Toxicol. Sci.
155, 234–247. 10.1093/toxsci/kfw200
</cite> [<a href="https://doi.org/10.1093/toxsci/kfw200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6093617/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27701120/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Toxicol.%20Sci.&amp;title=Comprehensive%20Translational%20Assessment%20of%20Human-Induced%20Pluripotent%20Stem%20Cell%20Derived%20Cardiomyocytes%20for%20Evaluating%20Drug-Induced%20Arrhythmias&amp;author=K.%20Blinova&amp;author=J.%20Stohlman&amp;author=J.%20Vicente&amp;author=D.%20Chan&amp;author=L.%20Johannesen&amp;volume=155&amp;publication_year=2017&amp;pages=234-247&amp;pmid=27701120&amp;doi=10.1093/toxsci/kfw200&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8">
<cite>
Borchard U., Boisten M. (1982). Effect of Flecainide on Action Potentials and Alternating Current-Induced Arrhythmias in Mammalian Myocardium. J. Cardiovasc. Pharmacol.
4, 205–212. 10.1097/00005344-198203000-00007
</cite> [<a href="https://doi.org/10.1097/00005344-198203000-00007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6175802/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Cardiovasc.%20Pharmacol.&amp;title=Effect%20of%20Flecainide%20on%20Action%20Potentials%20and%20Alternating%20Current-Induced%20Arrhythmias%20in%20Mammalian%20Myocardium&amp;author=U.%20Borchard&amp;author=M.%20Boisten&amp;volume=4&amp;publication_year=1982&amp;pages=205-212&amp;pmid=6175802&amp;doi=10.1097/00005344-198203000-00007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9">
<cite>
Burashnikov A., Belardinelli L., Antzelevitch C. (2012). Atrial-selective Sodium Channel Block Strategy to Suppress Atrial Fibrillation: Ranolazine versus Propafenone. J. Pharmacol. Exp. Ther.
340, 161–168. 10.1124/jpet.111.186395
</cite> [<a href="https://doi.org/10.1124/jpet.111.186395" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3251016/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22005044/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Pharmacol.%20Exp.%20Ther.&amp;title=Atrial-selective%20Sodium%20Channel%20Block%20Strategy%20to%20Suppress%20Atrial%20Fibrillation:%20Ranolazine%20versus%20Propafenone&amp;author=A.%20Burashnikov&amp;author=L.%20Belardinelli&amp;author=C.%20Antzelevitch&amp;volume=340&amp;publication_year=2012&amp;pages=161-168&amp;pmid=22005044&amp;doi=10.1124/jpet.111.186395&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10">
<cite>
Caballero R., Dolz-Gaitón P., Gómez R., Amorós I., Barana A., González de la Fuente M., et al.  (2010). Flecainide Increases Kir2.1 Currents by Interacting with Cysteine 311, Decreasing the Polyamine-Induced Rectification. Proc. Natl. Acad. Sci.
107, 15631–15636. 10.1073/pnas.1004021107
</cite> [<a href="https://doi.org/10.1073/pnas.1004021107" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2932566/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20713726/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc.%20Natl.%20Acad.%20Sci.&amp;title=Flecainide%20Increases%20Kir2.1%20Currents%20by%20Interacting%20with%20Cysteine%20311,%20Decreasing%20the%20Polyamine-Induced%20Rectification&amp;author=R.%20Caballero&amp;author=P.%20Dolz-Gait%C3%B3n&amp;author=R.%20G%C3%B3mez&amp;author=I.%20Amor%C3%B3s&amp;author=A.%20Barana&amp;volume=107&amp;publication_year=2010&amp;pages=15631-15636&amp;pmid=20713726&amp;doi=10.1073/pnas.1004021107&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11">
<cite>
Campuzano O., Sarquella-Brugada G., Cesar S., Arbelo E., Brugada J., Brugada R. (2018). Recent Advances in Short QT Syndrome. Front. Cardiovasc. Med.
5, 149. 10.3389/fcvm.2018.00149
</cite> [<a href="https://doi.org/10.3389/fcvm.2018.00149" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6215807/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30420954/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Cardiovasc.%20Med.&amp;title=Recent%20Advances%20in%20Short%20QT%20Syndrome&amp;author=O.%20Campuzano&amp;author=G.%20Sarquella-Brugada&amp;author=S.%20Cesar&amp;author=E.%20Arbelo&amp;author=J.%20Brugada&amp;volume=5&amp;publication_year=2018&amp;pages=149&amp;pmid=30420954&amp;doi=10.3389/fcvm.2018.00149&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12">
<cite>
Cordeiro J., Brugada R., Wu Y., Hong K., Dumaine R. (2005). Modulation of Inactivation by Mutation N588K in KCNH2: A Link to Arrhythmogenesis in Short QT Syndrome. Cardiovasc. Res.
67, 498–509. 10.1016/j.cardiores.2005.02.018
</cite> [<a href="https://doi.org/10.1016/j.cardiores.2005.02.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16039272/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovasc.%20Res.&amp;title=Modulation%20of%20Inactivation%20by%20Mutation%20N588K%20in%20KCNH2:%20A%20Link%20to%20Arrhythmogenesis%20in%20Short%20QT%20Syndrome&amp;author=J.%20Cordeiro&amp;author=R.%20Brugada&amp;author=Y.%20Wu&amp;author=K.%20Hong&amp;author=R.%20Dumaine&amp;volume=67&amp;publication_year=2005&amp;pages=498-509&amp;pmid=16039272&amp;doi=10.1016/j.cardiores.2005.02.018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13">
<cite>
Cyganek L., Tiburcy M., Sekeres K., Gerstenberg K., Bohnenberger H., Lenz C., et al.  (2018). Deep Phenotyping of Human Induced Pluripotent Stem Cell-Derived Atrial and Ventricular Cardiomyocytes. JCI insight
3, e99941. 10.1172/jci.insight.99941
</cite> [<a href="https://doi.org/10.1172/jci.insight.99941" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6124434/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29925689/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JCI%20insight&amp;title=Deep%20Phenotyping%20of%20Human%20Induced%20Pluripotent%20Stem%20Cell-Derived%20Atrial%20and%20Ventricular%20Cardiomyocytes&amp;author=L.%20Cyganek&amp;author=M.%20Tiburcy&amp;author=K.%20Sekeres&amp;author=K.%20Gerstenberg&amp;author=H.%20Bohnenberger&amp;volume=3&amp;publication_year=2018&amp;pages=e99941&amp;pmid=29925689&amp;doi=10.1172/jci.insight.99941&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14">
<cite>
Davidenko J. M., Cohen L., Goodrow R., Antzelevitch C. (1989). Quinidine-induced Action Potential Prolongation, Early Afterdepolarizations, and Triggered Activity in Canine Purkinje Fibers. Effects of Stimulation Rate, Potassium, and Magnesium. Circulation
79, 674–686. 10.1161/01.cir.79.3.674
</cite> [<a href="https://doi.org/10.1161/01.cir.79.3.674" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2917391/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Quinidine-induced%20Action%20Potential%20Prolongation,%20Early%20Afterdepolarizations,%20and%20Triggered%20Activity%20in%20Canine%20Purkinje%20Fibers.%20Effects%20of%20Stimulation%20Rate,%20Potassium,%20and%20Magnesium&amp;author=J.%20M.%20Davidenko&amp;author=L.%20Cohen&amp;author=R.%20Goodrow&amp;author=C.%20Antzelevitch&amp;volume=79&amp;publication_year=1989&amp;pages=674-686&amp;pmid=2917391&amp;doi=10.1161/01.cir.79.3.674&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15">
<cite>
Demontis G. C., Gargini C., Paoli T. G., Cervetto L. (2009). Selective Hcn1 Channels Inhibition by Ivabradine in Mouse Rod Photoreceptors. Invest. Ophthalmol. Vis. Sci.
50, 1948–1955. 10.1167/iovs.08-2659
</cite> [<a href="https://doi.org/10.1167/iovs.08-2659" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19060291/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Invest.%20Ophthalmol.%20Vis.%20Sci.&amp;title=Selective%20Hcn1%20Channels%20Inhibition%20by%20Ivabradine%20in%20Mouse%20Rod%20Photoreceptors&amp;author=G.%20C.%20Demontis&amp;author=C.%20Gargini&amp;author=T.%20G.%20Paoli&amp;author=L.%20Cervetto&amp;volume=50&amp;publication_year=2009&amp;pages=1948-1955&amp;pmid=19060291&amp;doi=10.1167/iovs.08-2659&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16">
<cite>
Du C., Zhang Y., El Harchi A., Dempsey C. E., Hancox J. C. (2014). Ranolazine Inhibition of hERG Potassium Channels: Drug-Pore Interactions and Reduced Potency against Inactivation Mutants. J. Mol. Cell. Cardiol.
74, 220–230. 10.1016/j.yjmcc.2014.05.013
</cite> [<a href="https://doi.org/10.1016/j.yjmcc.2014.05.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4121676/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24877995/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Mol.%20Cell.%20Cardiol.&amp;title=Ranolazine%20Inhibition%20of%20hERG%20Potassium%20Channels:%20Drug-Pore%20Interactions%20and%20Reduced%20Potency%20against%20Inactivation%20Mutants&amp;author=C.%20Du&amp;author=Y.%20Zhang&amp;author=A.%20El%20Harchi&amp;author=C.%20E.%20Dempsey&amp;author=J.%20C.%20Hancox&amp;volume=74&amp;publication_year=2014&amp;pages=220-230&amp;pmid=24877995&amp;doi=10.1016/j.yjmcc.2014.05.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17">
<cite>
El-Battrawy I., Lan H., Cyganek L., Zhao Z., Li X., Buljubasic F., et al.  (2018). Modeling Short QT Syndrome Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. J. Am. Heart Assoc.
7. 10.1161/JAHA.117.007394
</cite> [<a href="https://doi.org/10.1161/JAHA.117.007394" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5907581/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29574456/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Am.%20Heart%20Assoc.&amp;title=Modeling%20Short%20QT%20Syndrome%20Using%20Human-Induced%20Pluripotent%20Stem%20Cell-Derived%20Cardiomyocytes&amp;author=I.%20El-Battrawy&amp;author=H.%20Lan&amp;author=L.%20Cyganek&amp;author=Z.%20Zhao&amp;author=X.%20Li&amp;volume=7&amp;publication_year=2018&amp;pmid=29574456&amp;doi=10.1161/JAHA.117.007394&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18">
<cite>
El-Battrawy I., Zhao Z., Lan H., Schünemann J.-D., Sattler K., Buljubasic F., et al.  (2018). Estradiol Protection against Toxic Effects of Catecholamine on Electrical Properties in Human-Induced Pluripotent Stem Cell Derived Cardiomyocytes. Int. J. Cardiol.
254, 195–202. 10.1016/j.ijcard.2017.11.007
</cite> [<a href="https://doi.org/10.1016/j.ijcard.2017.11.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29407091/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Cardiol.&amp;title=Estradiol%20Protection%20against%20Toxic%20Effects%20of%20Catecholamine%20on%20Electrical%20Properties%20in%20Human-Induced%20Pluripotent%20Stem%20Cell%20Derived%20Cardiomyocytes&amp;author=I.%20El-Battrawy&amp;author=Z.%20Zhao&amp;author=H.%20Lan&amp;author=J.-D.%20Sch%C3%BCnemann&amp;author=K.%20Sattler&amp;volume=254&amp;publication_year=2018&amp;pages=195-202&amp;pmid=29407091&amp;doi=10.1016/j.ijcard.2017.11.007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19">
<cite>
El-Battrawy I., Besler J., Liebe V., Schimpf R., Tülümen E., Rudic B., et al.  (2018). Long-Term Follow-Up of Patients with Short QT Syndrome: Clinical Profile and Outcome. J. Am. Heart Assoc.
7, e010073. 10.1161/JAHA.118.010073
</cite> [<a href="https://doi.org/10.1161/JAHA.118.010073" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6405569/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30571592/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Am.%20Heart%20Assoc.&amp;title=Long-Term%20Follow-Up%20of%20Patients%20with%20Short%20QT%20Syndrome:%20Clinical%20Profile%20and%20Outcome&amp;author=I.%20El-Battrawy&amp;author=J.%20Besler&amp;author=V.%20Liebe&amp;author=R.%20Schimpf&amp;author=E.%20T%C3%BCl%C3%BCmen&amp;volume=7&amp;publication_year=2018&amp;pages=e010073&amp;pmid=30571592&amp;doi=10.1161/JAHA.118.010073&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20">
<cite>
El-Battrawy I., Besler J., Li X., Lan H., Zhao Z., Liebe V., et al.  (2019). Impact of Antiarrhythmic Drugs on the Outcome of Short QT Syndrome. Front. Pharmacol.
10, 771. 10.3389/fphar.2019.00771
</cite> [<a href="https://doi.org/10.3389/fphar.2019.00771" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6688193/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31427960/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Pharmacol.&amp;title=Impact%20of%20Antiarrhythmic%20Drugs%20on%20the%20Outcome%20of%20Short%20QT%20Syndrome&amp;author=I.%20El-Battrawy&amp;author=J.%20Besler&amp;author=X.%20Li&amp;author=H.%20Lan&amp;author=Z.%20Zhao&amp;volume=10&amp;publication_year=2019&amp;pages=771&amp;pmid=31427960&amp;doi=10.3389/fphar.2019.00771&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21">
<cite>
Follmer C. H., Colatsky T. J. (1990). Block of Delayed Rectifier Potassium Current, Ik, by Flecainide and E-4031 in Cat Ventricular Myocytes. Circulation
82, 289–293. 10.1161/01.cir.82.1.289
</cite> [<a href="https://doi.org/10.1161/01.cir.82.1.289" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2114236/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Block%20of%20Delayed%20Rectifier%20Potassium%20Current,%20Ik,%20by%20Flecainide%20and%20E-4031%20in%20Cat%20Ventricular%20Myocytes&amp;author=C.%20H.%20Follmer&amp;author=T.%20J.%20Colatsky&amp;volume=82&amp;publication_year=1990&amp;pages=289-293&amp;pmid=2114236&amp;doi=10.1161/01.cir.82.1.289&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B22">
<cite>
Frommeyer G., Schmidt M., Clauss C., Kaese S., Stypmann J., Pott C., et al.  (2012). Further Insights into the Underlying Electrophysiological Mechanisms for Reduction of Atrial Fibrillation by Ranolazine in an Experimental Model of Chronic Heart Failure. Eur. J. Heart Fail.
14, 1322–1331. 10.1093/eurjhf/hfs163
</cite> [<a href="https://doi.org/10.1093/eurjhf/hfs163" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23099358/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Heart%20Fail.&amp;title=Further%20Insights%20into%20the%20Underlying%20Electrophysiological%20Mechanisms%20for%20Reduction%20of%20Atrial%20Fibrillation%20by%20Ranolazine%20in%20an%20Experimental%20Model%20of%20Chronic%20Heart%20Failure&amp;author=G.%20Frommeyer&amp;author=M.%20Schmidt&amp;author=C.%20Clauss&amp;author=S.%20Kaese&amp;author=J.%20Stypmann&amp;volume=14&amp;publication_year=2012&amp;pages=1322-1331&amp;pmid=23099358&amp;doi=10.1093/eurjhf/hfs163&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23">
<cite>
Frommeyer G., Ellermann C., Dechering D. G., Kochhäuser S., Bögeholz N., Güner F., et al.  (2016). Ranolazine and Vernakalant Prevent Ventricular Arrhythmias in an Experimental Whole-Heart Model of Short QT Syndrome. J. Cardiovasc. Electrophysiol.
27, 1214–1219. 10.1111/jce.13029
</cite> [<a href="https://doi.org/10.1111/jce.13029" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27283775/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Cardiovasc.%20Electrophysiol.&amp;title=Ranolazine%20and%20Vernakalant%20Prevent%20Ventricular%20Arrhythmias%20in%20an%20Experimental%20Whole-Heart%20Model%20of%20Short%20QT%20Syndrome&amp;author=G.%20Frommeyer&amp;author=C.%20Ellermann&amp;author=D.%20G.%20Dechering&amp;author=S.%20Kochh%C3%A4user&amp;author=N.%20B%C3%B6geholz&amp;volume=27&amp;publication_year=2016&amp;pages=1214-1219&amp;pmid=27283775&amp;doi=10.1111/jce.13029&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24">
<cite>
Frommeyer G., Weller J., Ellermann C., Kaese S., Kochhäuser S., Lange P. S., et al.  (2017). Antiarrhythmic Properties of Ivabradine in an Experimental Model of Short-QT- Syndrome. Clin. Exp. Pharmacol. Physiol.
44, 941–945. 10.1111/1440-1681.12790
</cite> [<a href="https://doi.org/10.1111/1440-1681.12790" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28556923/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Exp.%20Pharmacol.%20Physiol.&amp;title=Antiarrhythmic%20Properties%20of%20Ivabradine%20in%20an%20Experimental%20Model%20of%20Short-QT-%20Syndrome&amp;author=G.%20Frommeyer&amp;author=J.%20Weller&amp;author=C.%20Ellermann&amp;author=S.%20Kaese&amp;author=S.%20Kochh%C3%A4user&amp;volume=44&amp;publication_year=2017&amp;pages=941-945&amp;pmid=28556923&amp;doi=10.1111/1440-1681.12790&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25">
<cite>
Frommeyer G., Garthmann J., Ellermann C., Dechering D. G., Kochhäuser S., Reinke F., et al.  (2018). Broad Antiarrhythmic Effect of Mexiletine in Different Arrhythmia Models. Electrophysiol. Eur. Soc. Cardiol.
20, 1375–1381. 10.1093/europace/eux221
</cite> [<a href="https://doi.org/10.1093/europace/eux221" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29016765/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Electrophysiol.%20Eur.%20Soc.%20Cardiol.&amp;title=Broad%20Antiarrhythmic%20Effect%20of%20Mexiletine%20in%20Different%20Arrhythmia%20Models&amp;author=G.%20Frommeyer&amp;author=J.%20Garthmann&amp;author=C.%20Ellermann&amp;author=D.%20G.%20Dechering&amp;author=S.%20Kochh%C3%A4user&amp;volume=20&amp;publication_year=2018&amp;pages=1375-1381&amp;pmid=29016765&amp;doi=10.1093/europace/eux221&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26">
<cite>
Gaita F., Giustetto C., Bianchi F., Schimpf R., Haissaguerre M., Calò L., et al.  (2004). Short QT Syndrome: Pharmacological Treatment. J. Am. Coll. Cardiol.
43, 1494–1499. 10.1016/j.jacc.2004.02.034
</cite> [<a href="https://doi.org/10.1016/j.jacc.2004.02.034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15093889/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Am.%20Coll.%20Cardiol.&amp;title=Short%20QT%20Syndrome:%20Pharmacological%20Treatment&amp;author=F.%20Gaita&amp;author=C.%20Giustetto&amp;author=F.%20Bianchi&amp;author=R.%20Schimpf&amp;author=M.%20Haissaguerre&amp;volume=43&amp;publication_year=2004&amp;pages=1494-1499&amp;pmid=15093889&amp;doi=10.1016/j.jacc.2004.02.034&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27">
<cite>
Giustetto C., Schimpf R., Mazzanti A., Scrocco C., Maury P., Anttonen O., et al.  (2011). Long-term Follow-Up of Patients with Short QT Syndrome. J. Am. Coll. Cardiol.
58, 587–595. 10.1016/j.jacc.2011.03.038
</cite> [<a href="https://doi.org/10.1016/j.jacc.2011.03.038" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21798421/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Am.%20Coll.%20Cardiol.&amp;title=Long-term%20Follow-Up%20of%20Patients%20with%20Short%20QT%20Syndrome&amp;author=C.%20Giustetto&amp;author=R.%20Schimpf&amp;author=A.%20Mazzanti&amp;author=C.%20Scrocco&amp;author=P.%20Maury&amp;volume=58&amp;publication_year=2011&amp;pages=587-595&amp;pmid=21798421&amp;doi=10.1016/j.jacc.2011.03.038&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28">
<cite>
Gualdani R., Tadini-Buoninsegni F., Roselli M., Defrenza I., Contino M., Colabufo N. A., et al.  (2015). Inhibition of hERG Potassium Channel by the Antiarrhythmic Agent Mexiletine and its Metabolite M-Hydroxymexiletine. Pharmacol. Res. Perspect.
3, e00160. 10.1002/prp2.160
</cite> [<a href="https://doi.org/10.1002/prp2.160" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4618635/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26516576/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol.%20Res.%20Perspect.&amp;title=Inhibition%20of%20hERG%20Potassium%20Channel%20by%20the%20Antiarrhythmic%20Agent%20Mexiletine%20and%20its%20Metabolite%20M-Hydroxymexiletine&amp;author=R.%20Gualdani&amp;author=F.%20Tadini-Buoninsegni&amp;author=M.%20Roselli&amp;author=I.%20Defrenza&amp;author=M.%20Contino&amp;volume=3&amp;publication_year=2015&amp;pages=e00160&amp;pmid=26516576&amp;doi=10.1002/prp2.160&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29">
<cite>
Guo F., Sun Y., Wang X., Wang H., Wang J., Gong T., et al.  (2019). Patient-Specific and Gene-Corrected Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Short QT Syndrome. Circ. Res.
124, 66–78. 10.1161/circresaha.118.313518
</cite> [<a href="https://doi.org/10.1161/circresaha.118.313518" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30582453/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circ.%20Res.&amp;title=Patient-Specific%20and%20Gene-Corrected%20Induced%20Pluripotent%20Stem%20Cell-Derived%20Cardiomyocytes%20Elucidate%20Single-Cell%20Phenotype%20of%20Short%20QT%20Syndrome&amp;author=F.%20Guo&amp;author=Y.%20Sun&amp;author=X.%20Wang&amp;author=H.%20Wang&amp;author=J.%20Wang&amp;volume=124&amp;publication_year=2019&amp;pages=66-78&amp;pmid=30582453&amp;doi=10.1161/circresaha.118.313518&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B30">
<cite>
Gussak I., Brugada P., Brugada J., Wright R. S., Kopecky S. L., Chaitman B. R., et al.  (2000). Idiopathic Short QT Interval:A New Clinical Syndrome?
Cardiology
94, 99–102. 10.1159/000047299
</cite> [<a href="https://doi.org/10.1159/000047299" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11173780/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiology&amp;title=Idiopathic%20Short%20QT%20Interval:A%20New%20Clinical%20Syndrome?&amp;author=I.%20Gussak&amp;author=P.%20Brugada&amp;author=J.%20Brugada&amp;author=R.%20S.%20Wright&amp;author=S.%20L.%20Kopecky&amp;volume=94&amp;publication_year=2000&amp;pages=99-102&amp;pmid=11173780&amp;doi=10.1159/000047299&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B31">
<cite>
Haechl N., Ebner J., Hilber K., Todt H., Koenig X. (2019). Pharmacological Profile of the Bradycardic Agent Ivabradine on Human Cardiac Ion Channels. Cell Physiol Biochem
53, 36–48. 10.33594/000000119
</cite> [<a href="https://doi.org/10.33594/000000119" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31169990/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Physiol%20Biochem&amp;title=Pharmacological%20Profile%20of%20the%20Bradycardic%20Agent%20Ivabradine%20on%20Human%20Cardiac%20Ion%20Channels&amp;author=N.%20Haechl&amp;author=J.%20Ebner&amp;author=K.%20Hilber&amp;author=H.%20Todt&amp;author=X.%20Koenig&amp;volume=53&amp;publication_year=2019&amp;pages=36-48&amp;pmid=31169990&amp;doi=10.33594/000000119&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B32">
<cite>
Imaizumi Y., Giles W. R. (1987). Quinidine-induced Inhibition of Transient Outward Current in Cardiac Muscle. Am. J. Physiology-Heart Circulatory Physiol.
253, H704–H708. 10.1152/ajpheart.1987.253.3.h704
</cite> [<a href="https://doi.org/10.1152/ajpheart.1987.253.3.h704" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2443024/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Physiology-Heart%20Circulatory%20Physiol.&amp;title=Quinidine-induced%20Inhibition%20of%20Transient%20Outward%20Current%20in%20Cardiac%20Muscle&amp;author=Y.%20Imaizumi&amp;author=W.%20R.%20Giles&amp;volume=253&amp;publication_year=1987&amp;pages=H704-H708&amp;pmid=2443024&amp;doi=10.1152/ajpheart.1987.253.3.h704&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B33">
<cite>
Iwamoto T., Watanabe Y., Kita S., Blaustein M. (2007). Na+/Ca2+ Exchange Inhibitors: a New Class of Calcium Regulators. Chddt
7, 188–198. 10.2174/187152907781745288
</cite> [<a href="https://doi.org/10.2174/187152907781745288" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17896959/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chddt&amp;title=Na+/Ca2+%20Exchange%20Inhibitors:%20a%20New%20Class%20of%20Calcium%20Regulators&amp;author=T.%20Iwamoto&amp;author=Y.%20Watanabe&amp;author=S.%20Kita&amp;author=M.%20Blaustein&amp;volume=7&amp;publication_year=2007&amp;pages=188-198&amp;pmid=17896959&amp;doi=10.2174/187152907781745288&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B34">
<cite>
Jæger K. H., Wall S., Tveito A. (2021). Computational Prediction of Drug Response in Short QT Syndrome Type 1 Based on Measurements of Compound Effect in Stem Cell-Derived Cardiomyocytes. Plos Comput. Biol.
17, e1008089. 10.1371/journal.pcbi.1008089
</cite> [<a href="https://doi.org/10.1371/journal.pcbi.1008089" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7909705/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33591962/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Plos%20Comput.%20Biol.&amp;title=Computational%20Prediction%20of%20Drug%20Response%20in%20Short%20QT%20Syndrome%20Type%201%20Based%20on%20Measurements%20of%20Compound%20Effect%20in%20Stem%20Cell-Derived%20Cardiomyocytes&amp;author=K.%20H.%20J%C3%A6ger&amp;author=S.%20Wall&amp;author=A.%20Tveito&amp;volume=17&amp;publication_year=2021&amp;pages=e1008089&amp;pmid=33591962&amp;doi=10.1371/journal.pcbi.1008089&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B35">
<cite>
Khodorov B. I., Zaborovskaya L. D. (1983). Blockade of Sodium and Potassium Channels in the Node of Ranvier by Ajmaline and N-Propyl Ajmaline. Gen. Physiol. Biophys.
2, 233–268. </cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/6088360/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gen.%20Physiol.%20Biophys.&amp;title=Blockade%20of%20Sodium%20and%20Potassium%20Channels%20in%20the%20Node%20of%20Ranvier%20by%20Ajmaline%20and%20N-Propyl%20Ajmaline&amp;author=B.%20I.%20Khodorov&amp;author=L.%20D.%20Zaborovskaya&amp;volume=2&amp;publication_year=1983&amp;pages=233-268&amp;pmid=6088360&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B36">
<cite>
Kiesecker C., Zitron E., Lück S., Bloehs R., Scholz E. P., Kathöfer S., et al.  (2004). Class Ia Anti-arrhythmic Drug Ajmaline Blocks HERG Potassium Channels: Mode of Action. Naunyn-schmiedeberg's Arch. Pharmacol.
370, 423–435. 10.1007/s00210-004-0976-8
</cite> [<a href="https://doi.org/10.1007/s00210-004-0976-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15599706/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Naunyn-schmiedeberg's%20Arch.%20Pharmacol.&amp;title=Class%20Ia%20Anti-arrhythmic%20Drug%20Ajmaline%20Blocks%20HERG%20Potassium%20Channels:%20Mode%20of%20Action&amp;author=C.%20Kiesecker&amp;author=E.%20Zitron&amp;author=S.%20L%C3%BCck&amp;author=R.%20Bloehs&amp;author=E.%20P.%20Scholz&amp;volume=370&amp;publication_year=2004&amp;pages=423-435&amp;pmid=15599706&amp;doi=10.1007/s00210-004-0976-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B37">
<cite>
Koepple C., Scherer D., Seyler C., Scholz E., Thomas D., Katus H. A., et al.  (2017). Dual Mechanism for Inhibition of Inwardly Rectifying Kir2.X Channels by Quinidine Involving Direct Pore Block and PIP2-Interference. J. Pharmacol. Exp. Ther.
361, 209–218. 10.1124/jpet.116.238287
</cite> [<a href="https://doi.org/10.1124/jpet.116.238287" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28188270/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Pharmacol.%20Exp.%20Ther.&amp;title=Dual%20Mechanism%20for%20Inhibition%20of%20Inwardly%20Rectifying%20Kir2.X%20Channels%20by%20Quinidine%20Involving%20Direct%20Pore%20Block%20and%20PIP2-Interference&amp;author=C.%20Koepple&amp;author=D.%20Scherer&amp;author=C.%20Seyler&amp;author=E.%20Scholz&amp;author=D.%20Thomas&amp;volume=361&amp;publication_year=2017&amp;pages=209-218&amp;pmid=28188270&amp;doi=10.1124/jpet.116.238287&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B38">
<cite>
Koncz I., Szél T., Bitay M., Cerbai E., Jaeger K., Fülöp F., et al.  (2011). Electrophysiological Effects of Ivabradine in Dog and Human Cardiac Preparations: Potential Antiarrhythmic Actions. Eur. J. Pharmacol.
668, 419–426. 10.1016/j.ejphar.2011.07.025
</cite> [<a href="https://doi.org/10.1016/j.ejphar.2011.07.025" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21821019/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Pharmacol.&amp;title=Electrophysiological%20Effects%20of%20Ivabradine%20in%20Dog%20and%20Human%20Cardiac%20Preparations:%20Potential%20Antiarrhythmic%20Actions&amp;author=I.%20Koncz&amp;author=T.%20Sz%C3%A9l&amp;author=M.%20Bitay&amp;author=E.%20Cerbai&amp;author=K.%20Jaeger&amp;volume=668&amp;publication_year=2011&amp;pages=419-426&amp;pmid=21821019&amp;doi=10.1016/j.ejphar.2011.07.025&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B39">
<cite>
Lan H., Xu Q., El-Battrawy I., Zhong R., Li X., Lang S., et al.  (2020). Ionic Mechanisms of Disopyramide Prolonging Action Potential Duration in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes from a Patient with Short QT Syndrome Type 1. Front. Pharmacol.
11, 554422. 10.3389/fphar.2020.554422
</cite> [<a href="https://doi.org/10.3389/fphar.2020.554422" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7586889/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33154722/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Pharmacol.&amp;title=Ionic%20Mechanisms%20of%20Disopyramide%20Prolonging%20Action%20Potential%20Duration%20in%20Human-Induced%20Pluripotent%20Stem%20Cell-Derived%20Cardiomyocytes%20from%20a%20Patient%20with%20Short%20QT%20Syndrome%20Type%201&amp;author=H.%20Lan&amp;author=Q.%20Xu&amp;author=I.%20El-Battrawy&amp;author=R.%20Zhong&amp;author=X.%20Li&amp;volume=11&amp;publication_year=2020&amp;pages=554422&amp;pmid=33154722&amp;doi=10.3389/fphar.2020.554422&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B40">
<cite>
Lees-Miller J. P., Guo J., Wang Y., Perissinotti L. L., Noskov S. Y., Duff H. J. (2015). Ivabradine Prolongs Phase 3 of Cardiac Repolarization and Blocks the hERG1 (KCNH2) Current over a Concentration-Range Overlapping with that Required to Block HCN4. J. Mol. Cell. Cardiol.
85, 71–78. 10.1016/j.yjmcc.2015.05.009
</cite> [<a href="https://doi.org/10.1016/j.yjmcc.2015.05.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25986146/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Mol.%20Cell.%20Cardiol.&amp;title=Ivabradine%20Prolongs%20Phase%203%20of%20Cardiac%20Repolarization%20and%20Blocks%20the%20hERG1%20(KCNH2)%20Current%20over%20a%20Concentration-Range%20Overlapping%20with%20that%20Required%20to%20Block%20HCN4&amp;author=J.%20P.%20Lees-Miller&amp;author=J.%20Guo&amp;author=Y.%20Wang&amp;author=L.%20L.%20Perissinotti&amp;author=S.%20Y.%20Noskov&amp;volume=85&amp;publication_year=2015&amp;pages=71-78&amp;pmid=25986146&amp;doi=10.1016/j.yjmcc.2015.05.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B41">
<cite>
Matsuo S., Kishida H., Munakata K., Atarashi H. (1985). The Effects of Mexiletine on Action Potential Duration and its Restitution in guinea Pig Ventricular Muscles. Jpn. Heart J.
26, 271–287. 10.1536/ihj.26.271
</cite> [<a href="https://doi.org/10.1536/ihj.26.271" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/4009969/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Jpn.%20Heart%20J.&amp;title=The%20Effects%20of%20Mexiletine%20on%20Action%20Potential%20Duration%20and%20its%20Restitution%20in%20guinea%20Pig%20Ventricular%20Muscles&amp;author=S.%20Matsuo&amp;author=H.%20Kishida&amp;author=K.%20Munakata&amp;author=H.%20Atarashi&amp;volume=26&amp;publication_year=1985&amp;pages=271-287&amp;pmid=4009969&amp;doi=10.1536/ihj.26.271&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B42">
<cite>
Mazzanti A., Maragna R., Vacanti G., Kostopoulou A., Marino M., Monteforte N., et al.  (2017). Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients with Short QT Syndrome. J. Am. Coll. Cardiol.
70, 3010–3015. 10.1016/j.jacc.2017.10.025
</cite> [<a href="https://doi.org/10.1016/j.jacc.2017.10.025" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29241489/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Am.%20Coll.%20Cardiol.&amp;title=Hydroquinidine%20Prevents%20Life-Threatening%20Arrhythmic%20Events%20in%20Patients%20with%20Short%20QT%20Syndrome&amp;author=A.%20Mazzanti&amp;author=R.%20Maragna&amp;author=G.%20Vacanti&amp;author=A.%20Kostopoulou&amp;author=M.%20Marino&amp;volume=70&amp;publication_year=2017&amp;pages=3010-3015&amp;pmid=29241489&amp;doi=10.1016/j.jacc.2017.10.025&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B43">
<cite>
McPate M. J., Duncan R. S., Hancox J. C., Witchel H. J. (2008). Pharmacology of the Short QT Syndrome N588K-hERG K+ Channel Mutation: Differential Impact on Selected Class I and Class III Antiarrhythmic Drugs. Br. J. Pharmacol.
155, 957–966. 10.1038/bjp.2008.325
</cite> [<a href="https://doi.org/10.1038/bjp.2008.325" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2597231/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18724381/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br.%20J.%20Pharmacol.&amp;title=Pharmacology%20of%20the%20Short%20QT%20Syndrome%20N588K-hERG%20K+%20Channel%20Mutation:%20Differential%20Impact%20on%20Selected%20Class%20I%20and%20Class%20III%20Antiarrhythmic%20Drugs&amp;author=M.%20J.%20McPate&amp;author=R.%20S.%20Duncan&amp;author=J.%20C.%20Hancox&amp;author=H.%20J.%20Witchel&amp;volume=155&amp;publication_year=2008&amp;pages=957-966&amp;pmid=18724381&amp;doi=10.1038/bjp.2008.325&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B44">
<cite>
Melgari D., Brack K. E., Zhang C., Zhang Y., El Harchi A., Mitcheson J. S., et al.  (2015). hERG Potassium Channel Blockade by the HCN Channel Inhibitor Bradycardic Agent Ivabradine. J. Am. Heart Assoc.
4, e001813. 10.1161/jaha.115.001813
</cite> [<a href="https://doi.org/10.1161/jaha.115.001813" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4579960/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25911606/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Am.%20Heart%20Assoc.&amp;title=hERG%20Potassium%20Channel%20Blockade%20by%20the%20HCN%20Channel%20Inhibitor%20Bradycardic%20Agent%20Ivabradine&amp;author=D.%20Melgari&amp;author=K.%20E.%20Brack&amp;author=C.%20Zhang&amp;author=Y.%20Zhang&amp;author=A.%20El%20Harchi&amp;volume=4&amp;publication_year=2015&amp;pages=e001813&amp;pmid=25911606&amp;doi=10.1161/jaha.115.001813&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B45">
<cite>
Melgari D., Zhang Y., El Harchi A., Dempsey C. E., Hancox J. C. (2015). Molecular Basis of hERG Potassium Channel Blockade by the Class Ic Antiarrhythmic Flecainide. J. Mol. Cell. Cardiol.
86, 42–53. 10.1016/j.yjmcc.2015.06.021
</cite> [<a href="https://doi.org/10.1016/j.yjmcc.2015.06.021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4564290/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26159617/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Mol.%20Cell.%20Cardiol.&amp;title=Molecular%20Basis%20of%20hERG%20Potassium%20Channel%20Blockade%20by%20the%20Class%20Ic%20Antiarrhythmic%20Flecainide&amp;author=D.%20Melgari&amp;author=Y.%20Zhang&amp;author=A.%20El%20Harchi&amp;author=C.%20E.%20Dempsey&amp;author=J.%20C.%20Hancox&amp;volume=86&amp;publication_year=2015&amp;pages=42-53&amp;pmid=26159617&amp;doi=10.1016/j.yjmcc.2015.06.021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B46">
<cite>
Michel D., Wegener J. W., Nawrath H. (2002). Effects of Quinine and Quinidine on the Transient Outward and on the L-type Ca2+ Current in Rat Ventricular Cardiomyocytes. Pharmacology
65, 187–192. 10.1159/000064342
</cite> [<a href="https://doi.org/10.1159/000064342" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12180412/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacology&amp;title=Effects%20of%20Quinine%20and%20Quinidine%20on%20the%20Transient%20Outward%20and%20on%20the%20L-type%20Ca2+%20Current%20in%20Rat%20Ventricular%20Cardiomyocytes&amp;author=D.%20Michel&amp;author=J.%20W.%20Wegener&amp;author=H.%20Nawrath&amp;volume=65&amp;publication_year=2002&amp;pages=187-192&amp;pmid=12180412&amp;doi=10.1159/000064342&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B47">
<cite>
Milberg P., Tegelkamp R., Osada N., Schimpf R., Wolpert C., Breithardt G., et al.  (2007). Reduction of Dispersion of Repolarization and Prolongation of Postrepolarization Refractoriness Explain the Antiarrhythmic Effects of Quinidine in a Model of Short QT Syndrome. J. Cardiovasc. Electrophysiol.
18, 658–664. 10.1111/j.1540-8167.2007.00813.x
</cite> [<a href="https://doi.org/10.1111/j.1540-8167.2007.00813.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17521304/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Cardiovasc.%20Electrophysiol.&amp;title=Reduction%20of%20Dispersion%20of%20Repolarization%20and%20Prolongation%20of%20Postrepolarization%20Refractoriness%20Explain%20the%20Antiarrhythmic%20Effects%20of%20Quinidine%20in%20a%20Model%20of%20Short%20QT%20Syndrome&amp;author=P.%20Milberg&amp;author=R.%20Tegelkamp&amp;author=N.%20Osada&amp;author=R.%20Schimpf&amp;author=C.%20Wolpert&amp;volume=18&amp;publication_year=2007&amp;pages=658-664&amp;pmid=17521304&amp;doi=10.1111/j.1540-8167.2007.00813.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B48">
<cite>
Miller D. C., Harmer S. C., Poliandri A., Nobles M., Edwards E. C., Ware J. S., et al.  (2017). Ajmaline Blocks I Na and I Kr without Eliciting Differences between Brugada Syndrome Patient and Control Human Pluripotent Stem Cell-Derived Cardiac Clusters. Stem Cel. Res.
25, 233–244. 10.1016/j.scr.2017.11.003
</cite> [<a href="https://doi.org/10.1016/j.scr.2017.11.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5727153/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29172153/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Stem%20Cel.%20Res.&amp;title=Ajmaline%20Blocks%20I%20Na%20and%20I%20Kr%20without%20Eliciting%20Differences%20between%20Brugada%20Syndrome%20Patient%20and%20Control%20Human%20Pluripotent%20Stem%20Cell-Derived%20Cardiac%20Clusters&amp;author=D.%20C.%20Miller&amp;author=S.%20C.%20Harmer&amp;author=A.%20Poliandri&amp;author=M.%20Nobles&amp;author=E.%20C.%20Edwards&amp;volume=25&amp;publication_year=2017&amp;pages=233-244&amp;pmid=29172153&amp;doi=10.1016/j.scr.2017.11.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B49">
<cite>
Mitcheson J. S., Hancox J. C. (1997). Modulation by Mexiletine of Action Potentials, L-type Ca Current and Delayed Rectifier K Current Recorded from Isolated Rabbit Atrioventricular Nodal Myocytes. Pflugers Archiv Eur. J. Physiol.
434, 855–858. 10.1007/s004240050476
</cite> [<a href="https://doi.org/10.1007/s004240050476" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9306023/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pflugers%20Archiv%20Eur.%20J.%20Physiol.&amp;title=Modulation%20by%20Mexiletine%20of%20Action%20Potentials,%20L-type%20Ca%20Current%20and%20Delayed%20Rectifier%20K%20Current%20Recorded%20from%20Isolated%20Rabbit%20Atrioventricular%20Nodal%20Myocytes&amp;author=J.%20S.%20Mitcheson&amp;author=J.%20C.%20Hancox&amp;volume=434&amp;publication_year=1997&amp;pages=855-858&amp;pmid=9306023&amp;doi=10.1007/s004240050476&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B50">
<cite>
Mizobuchi M., Enjoji Y., Yamamoto R., Ono T., Funatsu A., Kambayashi D., et al.  (2008). Nifekalant and Disopyramide in a Patient with Short QT Syndrome: Evaluation of Pharmacological Effects and Electrophysiological Properties. Pacing Clin. Electrophysiol. : PACE
31, 1229–1232. 10.1111/j.1540-8159.2008.01169.x
</cite> [<a href="https://doi.org/10.1111/j.1540-8159.2008.01169.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18834480/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pacing%20Clin.%20Electrophysiol.%20:%20PACE&amp;title=Nifekalant%20and%20Disopyramide%20in%20a%20Patient%20with%20Short%20QT%20Syndrome:%20Evaluation%20of%20Pharmacological%20Effects%20and%20Electrophysiological%20Properties&amp;author=M.%20Mizobuchi&amp;author=Y.%20Enjoji&amp;author=R.%20Yamamoto&amp;author=T.%20Ono&amp;author=A.%20Funatsu&amp;volume=31&amp;publication_year=2008&amp;pages=1229-1232&amp;pmid=18834480&amp;doi=10.1111/j.1540-8159.2008.01169.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B51">
<cite>
Nishida A., Takizawa T., Matsumoto A., Miki T., Seino S., Nakaya H. (2011). Inhibition of ATP-Sensitive K+ Channels and L-type Ca2+ Channels by Amiodarone Elicits Contradictory Effect on Insulin Secretion in MIN6 Cells. J. Pharmacol. Sci.
116, 73–80. 10.1254/jphs.10294fp
</cite> [<a href="https://doi.org/10.1254/jphs.10294fp" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21512308/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Pharmacol.%20Sci.&amp;title=Inhibition%20of%20ATP-Sensitive%20K+%20Channels%20and%20L-type%20Ca2+%20Channels%20by%20Amiodarone%20Elicits%20Contradictory%20Effect%20on%20Insulin%20Secretion%20in%20MIN6%20Cells&amp;author=A.%20Nishida&amp;author=T.%20Takizawa&amp;author=A.%20Matsumoto&amp;author=T.%20Miki&amp;author=S.%20Seino&amp;volume=116&amp;publication_year=2011&amp;pages=73-80&amp;pmid=21512308&amp;doi=10.1254/jphs.10294fp&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B52">
<cite>
Paul A. A., Witchel H. J., Hancox J. C. (2002). Inhibition of the Current of Heterologously Expressed HERG Potassium Channels by Flecainide and Comparison with Quinidine, Propafenone and Lignocaine. Br. J. Pharmacol.
136, 717–729. 10.1038/sj.bjp.0704784
</cite> [<a href="https://doi.org/10.1038/sj.bjp.0704784" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1573407/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12086981/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br.%20J.%20Pharmacol.&amp;title=Inhibition%20of%20the%20Current%20of%20Heterologously%20Expressed%20HERG%20Potassium%20Channels%20by%20Flecainide%20and%20Comparison%20with%20Quinidine,%20Propafenone%20and%20Lignocaine&amp;author=A.%20A.%20Paul&amp;author=H.%20J.%20Witchel&amp;author=J.%20C.%20Hancox&amp;volume=136&amp;publication_year=2002&amp;pages=717-729&amp;pmid=12086981&amp;doi=10.1038/sj.bjp.0704784&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B53">
<cite>
Perrin M. J., Kuchel P. W., Campbell T. J., Vandenberg J. I. (2008). Drug Binding to the Inactivated State Is Necessary but Not Sufficient for High-Affinity Binding to Human Ether-À-Go-Go-Related Gene Channels. Mol. Pharmacol.
74, 1443–1452. 10.1124/mol.108.049056
</cite> [<a href="https://doi.org/10.1124/mol.108.049056" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18701618/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Pharmacol.&amp;title=Drug%20Binding%20to%20the%20Inactivated%20State%20Is%20Necessary%20but%20Not%20Sufficient%20for%20High-Affinity%20Binding%20to%20Human%20Ether-%C3%80-Go-Go-Related%20Gene%20Channels&amp;author=M.%20J.%20Perrin&amp;author=P.%20W.%20Kuchel&amp;author=T.%20J.%20Campbell&amp;author=J.%20I.%20Vandenberg&amp;volume=74&amp;publication_year=2008&amp;pages=1443-1452&amp;pmid=18701618&amp;doi=10.1124/mol.108.049056&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B54">
<cite>
Priori S. G., Blomström-Lundqvist C., Mazzanti A., Blom N., Borggrefe M., Camm J., et al.  (2015). 2015 ESC Guidelines for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Europace
17, 1601–1687. 10.1093/europace/euv319
</cite> [<a href="https://doi.org/10.1093/europace/euv319" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26318695/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Europace&amp;title=2015%20ESC%20Guidelines%20for%20the%20Management%20of%20Patients%20with%20Ventricular%20Arrhythmias%20and%20the%20Prevention%20of%20Sudden%20Cardiac%20Death:%20The%20Task%20Force%20for%20the%20Management%20of%20Patients%20with%20Ventricular%20Arrhythmias%20and%20the%20Prevention%20of%20Sudden%20Cardiac%20Death%20of%20the%20European%20Society%20of%20Cardiology%20(ESC)Endorsed%20by:%20Association%20for%20European%20Paediatric%20and%20Congenital%20Cardiology%20(AEPC)&amp;author=S.%20G.%20Priori&amp;author=C.%20Blomstr%C3%B6m-Lundqvist&amp;author=A.%20Mazzanti&amp;author=N.%20Blom&amp;author=M.%20Borggrefe&amp;volume=17&amp;publication_year=2015&amp;pages=1601-1687&amp;pmid=26318695&amp;doi=10.1093/europace/euv319&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B55">
<cite>
Pugsley M. K., Walker M. J., Saint D. A. (2005). Block of NA+ and K+ Currents in Rat Ventricular Myocytes by Quinacainol and Quinidine. Clin. Exp. Pharmacol. Physiol.
32, 60–65. 10.1111/j.1440-1681.2005.04149.x
</cite> [<a href="https://doi.org/10.1111/j.1440-1681.2005.04149.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15730436/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Exp.%20Pharmacol.%20Physiol.&amp;title=Block%20of%20NA+%20and%20K+%20Currents%20in%20Rat%20Ventricular%20Myocytes%20by%20Quinacainol%20and%20Quinidine&amp;author=M.%20K.%20Pugsley&amp;author=M.%20J.%20Walker&amp;author=D.%20A.%20Saint&amp;volume=32&amp;publication_year=2005&amp;pages=60-65&amp;pmid=15730436&amp;doi=10.1111/j.1440-1681.2005.04149.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B56">
<cite>
Qian C., Ma J., Zhang P., Luo A., Wang C., Ren Z., et al.  (2012). Resveratrol Attenuates the Na(+)-dependent Intracellular Ca(2+) Overload by Inhibiting H(2)O(2)-induced Increase in Late Sodium Current in Ventricular Myocytes. PloS one
7, e51358. 10.1371/journal.pone.0051358
</cite> [<a href="https://doi.org/10.1371/journal.pone.0051358" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3521760/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23272101/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PloS%20one&amp;title=Resveratrol%20Attenuates%20the%20Na(+)-dependent%20Intracellular%20Ca(2+)%20Overload%20by%20Inhibiting%20H(2)O(2)-induced%20Increase%20in%20Late%20Sodium%20Current%20in%20Ventricular%20Myocytes&amp;author=C.%20Qian&amp;author=J.%20Ma&amp;author=P.%20Zhang&amp;author=A.%20Luo&amp;author=C.%20Wang&amp;volume=7&amp;publication_year=2012&amp;pages=e51358&amp;pmid=23272101&amp;doi=10.1371/journal.pone.0051358&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B57">
<cite>
Rahm A.-K., Müller M. E., Gramlich D., Lugenbiel P., Uludag E., Rivinius R., et al.  (2020). Inhibition of Cardiac Kv4.3 (Ito) Channel Isoforms by Class I Antiarrhythmic Drugs Lidocaine and Mexiletine. Eur. J. Pharmacol.
880, 173159. 10.1016/j.ejphar.2020.173159
</cite> [<a href="https://doi.org/10.1016/j.ejphar.2020.173159" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32360350/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Pharmacol.&amp;title=Inhibition%20of%20Cardiac%20Kv4.3%20(Ito)%20Channel%20Isoforms%20by%20Class%20I%20Antiarrhythmic%20Drugs%20Lidocaine%20and%20Mexiletine&amp;author=A.-K.%20Rahm&amp;author=M.%20E.%20M%C3%BCller&amp;author=D.%20Gramlich&amp;author=P.%20Lugenbiel&amp;author=E.%20Uludag&amp;volume=880&amp;publication_year=2020&amp;pages=173159&amp;pmid=32360350&amp;doi=10.1016/j.ejphar.2020.173159&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B58">
<cite>
Rajamani S., Shryock J. C., Belardinelli L. (2008). Rapid Kinetic Interactions of Ranolazine with HERG K+ Current. J. Cardiovasc. Pharmacol.
51, 581–589. 10.1097/fjc.0b013e3181799690
</cite> [<a href="https://doi.org/10.1097/fjc.0b013e3181799690" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18520952/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Cardiovasc.%20Pharmacol.&amp;title=Rapid%20Kinetic%20Interactions%20of%20Ranolazine%20with%20HERG%20K+%20Current&amp;author=S.%20Rajamani&amp;author=J.%20C.%20Shryock&amp;author=L.%20Belardinelli&amp;volume=51&amp;publication_year=2008&amp;pages=581-589&amp;pmid=18520952&amp;doi=10.1097/fjc.0b013e3181799690&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B59">
<cite>
Salvage S. C., Chandrasekharan K. H., Jeevaratnam K., Dulhunty A. F., Thompson A. J., Jackson A. P., et al.  (2018). Multiple Targets for Flecainide Action: Implications for Cardiac Arrhythmogenesis. Br. J. Pharmacol.
175, 1260–1278. 10.1111/bph.13807
</cite> [<a href="https://doi.org/10.1111/bph.13807" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5866987/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28369767/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br.%20J.%20Pharmacol.&amp;title=Multiple%20Targets%20for%20Flecainide%20Action:%20Implications%20for%20Cardiac%20Arrhythmogenesis&amp;author=S.%20C.%20Salvage&amp;author=K.%20H.%20Chandrasekharan&amp;author=K.%20Jeevaratnam&amp;author=A.%20F.%20Dulhunty&amp;author=A.%20J.%20Thompson&amp;volume=175&amp;publication_year=2018&amp;pages=1260-1278&amp;pmid=28369767&amp;doi=10.1111/bph.13807&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B60">
<cite>
Sanguinetti M. C., Jiang C., Curran M. E., Keating M. T. (1995). A Mechanistic Link between an Inherited and an Acquird Cardiac Arrthytmia: HERG Encodes the IKr Potassium Channel. Cell
81, 299–307. 10.1016/0092-8674(95)90340-2
</cite> [<a href="https://doi.org/10.1016/0092-8674(95)90340-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7736582/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=A%20Mechanistic%20Link%20between%20an%20Inherited%20and%20an%20Acquird%20Cardiac%20Arrthytmia:%20HERG%20Encodes%20the%20IKr%20Potassium%20Channel&amp;author=M.%20C.%20Sanguinetti&amp;author=C.%20Jiang&amp;author=M.%20E.%20Curran&amp;author=M.%20T.%20Keating&amp;volume=81&amp;publication_year=1995&amp;pages=299-307&amp;pmid=7736582&amp;doi=10.1016/0092-8674(95)90340-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B61">
<cite>
Sasaki N., Watanabe I., Kogawa R., Sonoda K., Takahashi K., Okumura Y., et al.  (2014). Effects of Intravenous Amiodarone and Ibutilide on Action Potential Duration and Atrial Conduction Kinetics in Patients with Persistent Atrial Fibrillation. Int. Heart J.
55, 244–248. 10.1536/ihj.13-254
</cite> [<a href="https://doi.org/10.1536/ihj.13-254" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24806377/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20Heart%20J.&amp;title=Effects%20of%20Intravenous%20Amiodarone%20and%20Ibutilide%20on%20Action%20Potential%20Duration%20and%20Atrial%20Conduction%20Kinetics%20in%20Patients%20with%20Persistent%20Atrial%20Fibrillation&amp;author=N.%20Sasaki&amp;author=I.%20Watanabe&amp;author=R.%20Kogawa&amp;author=K.%20Sonoda&amp;author=K.%20Takahashi&amp;volume=55&amp;publication_year=2014&amp;pages=244-248&amp;pmid=24806377&amp;doi=10.1536/ihj.13-254&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B62">
<cite>
Sato T., Shigematsu S., Arita M. (1995). Mexiletine-induced Shortening of the Action Potential Duration of Ventricular Muscles by Activation of ATP-Sensitive K+ Channels. Br. J. Pharmacol.
115, 381–382. 10.1111/j.1476-5381.1995.tb16342.x
</cite> [<a href="https://doi.org/10.1111/j.1476-5381.1995.tb16342.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1908414/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7582444/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br.%20J.%20Pharmacol.&amp;title=Mexiletine-induced%20Shortening%20of%20the%20Action%20Potential%20Duration%20of%20Ventricular%20Muscles%20by%20Activation%20of%20ATP-Sensitive%20K+%20Channels&amp;author=T.%20Sato&amp;author=S.%20Shigematsu&amp;author=M.%20Arita&amp;volume=115&amp;publication_year=1995&amp;pages=381-382&amp;pmid=7582444&amp;doi=10.1111/j.1476-5381.1995.tb16342.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B63">
<cite>
Schönherr R., Heinemann S. H. (1996). Molecular Determinants for Activation and Inactivation of HERG, a Human Inward Rectifier Potassium Channel. J. Physiol.
493 (Pt 3), 635–642. 10.1113/jphysiol.1996.sp021410
</cite> [<a href="https://doi.org/10.1113/jphysiol.1996.sp021410" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1159013/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8799887/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Physiol.&amp;title=Molecular%20Determinants%20for%20Activation%20and%20Inactivation%20of%20HERG,%20a%20Human%20Inward%20Rectifier%20Potassium%20Channel&amp;author=R.%20Sch%C3%B6nherr&amp;author=S.%20H.%20Heinemann&amp;volume=493&amp;issue=Pt%203&amp;publication_year=1996&amp;pages=635-642&amp;pmid=8799887&amp;doi=10.1113/jphysiol.1996.sp021410&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B64">
<cite>
Schram G., Zhang L., Derakhchan K., Ehrlich J. R., Belardinelli L., Nattel S. (2004). Ranolazine: Ion-Channel-Blocking Actions and In Vivo Electrophysiological Effects. Br. J. Pharmacol.
142, 1300–1308. 10.1038/sj.bjp.0705879
</cite> [<a href="https://doi.org/10.1038/sj.bjp.0705879" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1575187/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15277312/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br.%20J.%20Pharmacol.&amp;title=Ranolazine:%20Ion-Channel-Blocking%20Actions%20and%20In%20Vivo%20Electrophysiological%20Effects&amp;author=G.%20Schram&amp;author=L.%20Zhang&amp;author=K.%20Derakhchan&amp;author=J.%20R.%20Ehrlich&amp;author=L.%20Belardinelli&amp;volume=142&amp;publication_year=2004&amp;pages=1300-1308&amp;pmid=15277312&amp;doi=10.1038/sj.bjp.0705879&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B65">
<cite>
Shinnawi R., Shaheen N., Huber I., Shiti A., Arbel G., Gepstein A., et al.  (2019). Modeling Reentry in the Short QT Syndrome with Human-Induced Pluripotent Stem Cell-Derived Cardiac Cell Sheets. J. Am. Coll. Cardiol.
73, 2310–2324. 10.1016/j.jacc.2019.02.055
</cite> [<a href="https://doi.org/10.1016/j.jacc.2019.02.055" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31072576/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Am.%20Coll.%20Cardiol.&amp;title=Modeling%20Reentry%20in%20the%20Short%20QT%20Syndrome%20with%20Human-Induced%20Pluripotent%20Stem%20Cell-Derived%20Cardiac%20Cell%20Sheets&amp;author=R.%20Shinnawi&amp;author=N.%20Shaheen&amp;author=I.%20Huber&amp;author=A.%20Shiti&amp;author=G.%20Arbel&amp;volume=73&amp;publication_year=2019&amp;pages=2310-2324&amp;pmid=31072576&amp;doi=10.1016/j.jacc.2019.02.055&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B66">
<cite>
Snyders D. J., Chaudhary A. (1996). High Affinity Open Channel Block by Dofetilide of HERG Expressed in a Human Cell Line. Mol. Pharmacol.
49, 949–955. </cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/8649354/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Pharmacol.&amp;title=High%20Affinity%20Open%20Channel%20Block%20by%20Dofetilide%20of%20HERG%20Expressed%20in%20a%20Human%20Cell%20Line&amp;author=D.%20J.%20Snyders&amp;author=A.%20Chaudhary&amp;volume=49&amp;publication_year=1996&amp;pages=949-955&amp;pmid=8649354&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B67">
<cite>
Suzuki T., Morishima M., Kato S., Ueda N., Honjo H., Kamiya K. (2013). Atrial Selectivity in Na+channel Blockade by Acute Amiodarone. Cardiovasc. Res.
98, 136–144. 10.1093/cvr/cvt007
</cite> [<a href="https://doi.org/10.1093/cvr/cvt007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23341577/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovasc.%20Res.&amp;title=Atrial%20Selectivity%20in%20Na+channel%20Blockade%20by%20Acute%20Amiodarone&amp;author=T.%20Suzuki&amp;author=M.%20Morishima&amp;author=S.%20Kato&amp;author=N.%20Ueda&amp;author=H.%20Honjo&amp;volume=98&amp;publication_year=2013&amp;pages=136-144&amp;pmid=23341577&amp;doi=10.1093/cvr/cvt007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B68">
<cite>
Thorsen K., Dam V. S., Kjaer-Sorensen K., Pedersen L. N., Skeberdis V. A., Jurevicius J., et al.  (2017). Loss-of-activity-mutation in the Cardiac Chloride-Bicarbonate Exchanger AE3 Causes Short QT Syndrome. Nat. Commun.
8, 1696. 10.1038/s41467-017-01630-0
</cite> [<a href="https://doi.org/10.1038/s41467-017-01630-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5700076/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29167417/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Commun.&amp;title=Loss-of-activity-mutation%20in%20the%20Cardiac%20Chloride-Bicarbonate%20Exchanger%20AE3%20Causes%20Short%20QT%20Syndrome&amp;author=K.%20Thorsen&amp;author=V.%20S.%20Dam&amp;author=K.%20Kjaer-Sorensen&amp;author=L.%20N.%20Pedersen&amp;author=V.%20A.%20Skeberdis&amp;volume=8&amp;publication_year=2017&amp;pages=1696&amp;pmid=29167417&amp;doi=10.1038/s41467-017-01630-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B69">
<cite>
Trudeau M., Warmke J., Ganetzky B., Robertson G. (1995). HERG, a Human Inward Rectifier in the Voltage-Gated Potassium Channel Family. Science
269, 92–95. 10.1126/science.7604285
</cite> [<a href="https://doi.org/10.1126/science.7604285" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7604285/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=HERG,%20a%20Human%20Inward%20Rectifier%20in%20the%20Voltage-Gated%20Potassium%20Channel%20Family&amp;author=M.%20Trudeau&amp;author=J.%20Warmke&amp;author=B.%20Ganetzky&amp;author=G.%20Robertson&amp;volume=269&amp;publication_year=1995&amp;pages=92-95&amp;pmid=7604285&amp;doi=10.1126/science.7604285&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B70">
<cite>
Undrovinas A. I., Burnashev N., Eroshenko D., Fleidervish I., Starmer C. F., Makielski J. C., et al.  (1990). Quinidine Blocks Adenosine 5'-Triphosphate-Sensitive Potassium Channels in Heart. Am. J. Physiology-Heart Circulatory Physiol.
259, H1609–H1612. 10.1152/ajpheart.1990.259.5.h1609
</cite> [<a href="https://doi.org/10.1152/ajpheart.1990.259.5.h1609" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2240258/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Physiology-Heart%20Circulatory%20Physiol.&amp;title=Quinidine%20Blocks%20Adenosine%205'-Triphosphate-Sensitive%20Potassium%20Channels%20in%20Heart&amp;author=A.%20I.%20Undrovinas&amp;author=N.%20Burnashev&amp;author=D.%20Eroshenko&amp;author=I.%20Fleidervish&amp;author=C.%20F.%20Starmer&amp;volume=259&amp;publication_year=1990&amp;pages=H1609-H1612&amp;pmid=2240258&amp;doi=10.1152/ajpheart.1990.259.5.h1609&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B71">
<cite>
Wang Z., Fermini B., Nattel S. (1993). Mechanism of Flecainide's Rate-dependent Actions on Action Potential Duration in Canine Atrial Tissue. J. Pharmacol. Exp. Ther.
267, 575–581. </cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/8246130/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Pharmacol.%20Exp.%20Ther.&amp;title=Mechanism%20of%20Flecainide's%20Rate-dependent%20Actions%20on%20Action%20Potential%20Duration%20in%20Canine%20Atrial%20Tissue&amp;author=Z.%20Wang&amp;author=B.%20Fermini&amp;author=S.%20Nattel&amp;volume=267&amp;publication_year=1993&amp;pages=575-581&amp;pmid=8246130&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B72">
<cite>
Wang D., Kiyosue T., Sato T., Arita M. (1996). Comparison of the Effects of Class I Anti-arrhythmic Drugs, Cibenzoline, Mexiletine and Flecainide, on the Delayed Rectifier K+Current of Guinea-pig Ventricular Myocytes. J. Mol. Cell. Cardiol.
28, 893–903. 10.1006/jmcc.1996.0084
</cite> [<a href="https://doi.org/10.1006/jmcc.1996.0084" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8762029/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Mol.%20Cell.%20Cardiol.&amp;title=Comparison%20of%20the%20Effects%20of%20Class%20I%20Anti-arrhythmic%20Drugs,%20Cibenzoline,%20Mexiletine%20and%20Flecainide,%20on%20the%20Delayed%20Rectifier%20K+Current%20of%20Guinea-pig%20Ventricular%20Myocytes&amp;author=D.%20Wang&amp;author=T.%20Kiyosue&amp;author=T.%20Sato&amp;author=M.%20Arita&amp;volume=28&amp;publication_year=1996&amp;pages=893-903&amp;pmid=8762029&amp;doi=10.1006/jmcc.1996.0084&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B73">
<cite>
Wang S., Liu S., Morales M. J., Strauss H. C., Rasmusson R. L. (1997). A Quantitative Analysis of the Activation and Inactivation Kinetics of HERG Expressed in <em>Xenopus</em> Oocytes. J. Physiol.
502 (Pt 1), 45–60. 10.1111/j.1469-7793.1997.045bl.x
</cite> [<a href="https://doi.org/10.1111/j.1469-7793.1997.045bl.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1159571/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9234196/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Physiol.&amp;title=A%20Quantitative%20Analysis%20of%20the%20Activation%20and%20Inactivation%20Kinetics%20of%20HERG%20Expressed%20in%20Xenopus%20Oocytes&amp;author=S.%20Wang&amp;author=S.%20Liu&amp;author=M.%20J.%20Morales&amp;author=H.%20C.%20Strauss&amp;author=R.%20L.%20Rasmusson&amp;volume=502&amp;issue=Pt%201&amp;publication_year=1997&amp;pages=45-60&amp;pmid=9234196&amp;doi=10.1111/j.1469-7793.1997.045bl.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B74">
<cite>
Wang J., Della Penna K., Wang H., Karczewski J., Connolly T. M., Koblan K. S., et al.  (2003). Functional and Pharmacological Properties of Canine ERG Potassium Channels. Am. J. Physiology-Heart Circulatory Physiol.
284, H256–H267. 10.1152/ajpheart.00220.2002
</cite> [<a href="https://doi.org/10.1152/ajpheart.00220.2002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12388285/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Physiology-Heart%20Circulatory%20Physiol.&amp;title=Functional%20and%20Pharmacological%20Properties%20of%20Canine%20ERG%20Potassium%20Channels&amp;author=J.%20Wang&amp;author=K.%20Della%20Penna&amp;author=H.%20Wang&amp;author=J.%20Karczewski&amp;author=T.%20M.%20Connolly&amp;volume=284&amp;publication_year=2003&amp;pages=H256-H267&amp;pmid=12388285&amp;doi=10.1152/ajpheart.00220.2002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B75">
<cite>
Watanabe Y. (2019). Cardiac Na+/Ca2+ Exchange Stimulators Among Cardioprotective Drugs. J. Physiol. Sci.
69, 837–849. 10.1007/s12576-019-00721-5
</cite> [<a href="https://doi.org/10.1007/s12576-019-00721-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10717683/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31664641/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Physiol.%20Sci.&amp;title=Cardiac%20Na+/Ca2+%20Exchange%20Stimulators%20Among%20Cardioprotective%20Drugs&amp;author=Y.%20Watanabe&amp;volume=69&amp;publication_year=2019&amp;pages=837-849&amp;pmid=31664641&amp;doi=10.1007/s12576-019-00721-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B76">
<cite>
Wu L., Shryock J. C., Song Y., Li Y., Antzelevitch C., Belardinelli L. (2004). Antiarrhythmic Effects of Ranolazine in a guinea Pig In Vitro Model of Long-QT Syndrome. J. Pharmacol. Exp. Ther.
310, 599–605. 10.1124/jpet.104.066100
</cite> [<a href="https://doi.org/10.1124/jpet.104.066100" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15031300/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Pharmacol.%20Exp.%20Ther.&amp;title=Antiarrhythmic%20Effects%20of%20Ranolazine%20in%20a%20guinea%20Pig%20In%20Vitro%20Model%20of%20Long-QT%20Syndrome&amp;author=L.%20Wu&amp;author=J.%20C.%20Shryock&amp;author=Y.%20Song&amp;author=Y.%20Li&amp;author=C.%20Antzelevitch&amp;volume=310&amp;publication_year=2004&amp;pages=599-605&amp;pmid=15031300&amp;doi=10.1124/jpet.104.066100&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B77">
<cite>
Yang T., Kanki H., Zhang W., Roden D. M. (2009). Probing the Mechanisms Underlying Modulation of Quinidine Sensitivity to Cardiac IKsblock by Protein Kinase A-Mediated IKsphosphorylation. Br. J. Pharmacol.
157, 952–961. 10.1111/j.1476-5381.2009.00293.x
</cite> [<a href="https://doi.org/10.1111/j.1476-5381.2009.00293.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2737654/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19522859/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br.%20J.%20Pharmacol.&amp;title=Probing%20the%20Mechanisms%20Underlying%20Modulation%20of%20Quinidine%20Sensitivity%20to%20Cardiac%20IKsblock%20by%20Protein%20Kinase%20A-Mediated%20IKsphosphorylation&amp;author=T.%20Yang&amp;author=H.%20Kanki&amp;author=W.%20Zhang&amp;author=D.%20M.%20Roden&amp;volume=157&amp;publication_year=2009&amp;pages=952-961&amp;pmid=19522859&amp;doi=10.1111/j.1476-5381.2009.00293.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B78">
<cite>
Yonemizu S., Masuda K., Kurata Y., Notsu T., Higashi Y., Fukumura K., et al.  (2019). Inhibitory Effects of Class I Antiarrhythmic Agents on Na+ and Ca2+ Currents of Human iPS Cell-Derived Cardiomyocytes. Regenerative Ther.
10, 104–111. 10.1016/j.reth.2018.12.002
</cite> [<a href="https://doi.org/10.1016/j.reth.2018.12.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6360514/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30766898/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Regenerative%20Ther.&amp;title=Inhibitory%20Effects%20of%20Class%20I%20Antiarrhythmic%20Agents%20on%20Na+%20and%20Ca2+%20Currents%20of%20Human%20iPS%20Cell-Derived%20Cardiomyocytes&amp;author=S.%20Yonemizu&amp;author=K.%20Masuda&amp;author=Y.%20Kurata&amp;author=T.%20Notsu&amp;author=Y.%20Higashi&amp;volume=10&amp;publication_year=2019&amp;pages=104-111&amp;pmid=30766898&amp;doi=10.1016/j.reth.2018.12.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B79">
<cite>
Youm J. B., Earm Y. E., Ho W. K. (2004). Modulation of HERG Channel Inactivation by External Cations. Eur. Biophys. J. : EBJ
33, 360–369. 10.1007/s00249-003-0367-y
</cite> [<a href="https://doi.org/10.1007/s00249-003-0367-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14586519/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20Biophys.%20J.%20:%20EBJ&amp;title=Modulation%20of%20HERG%20Channel%20Inactivation%20by%20External%20Cations&amp;author=J.%20B.%20Youm&amp;author=Y.%20E.%20Earm&amp;author=W.%20K.%20Ho&amp;volume=33&amp;publication_year=2004&amp;pages=360-369&amp;pmid=14586519&amp;doi=10.1007/s00249-003-0367-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B80">
<cite>
Yunoki T., Teramoto N., Naito S., Ito Y. (2001). The Effects of Flecainide on ATP-Sensitive K+ Channels in Pig Urethral Myocytes. Br. J. Pharmacol.
133, 730–738. 10.1038/sj.bjp.0704109
</cite> [<a href="https://doi.org/10.1038/sj.bjp.0704109" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1572826/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11429398/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br.%20J.%20Pharmacol.&amp;title=The%20Effects%20of%20Flecainide%20on%20ATP-Sensitive%20K+%20Channels%20in%20Pig%20Urethral%20Myocytes&amp;author=T.%20Yunoki&amp;author=N.%20Teramoto&amp;author=S.%20Naito&amp;author=Y.%20Ito&amp;volume=133&amp;publication_year=2001&amp;pages=730-738&amp;pmid=11429398&amp;doi=10.1038/sj.bjp.0704109&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B81">
<cite>
Zhang S., Zhou Z., Gong Q., Makielski J. C., January C. T. (1999). Mechanism of Block and Identification of the Verapamil Binding Domain to HERG Potassium Channels. Circ. Res.
84, 989–998. 10.1161/01.res.84.9.989
</cite> [<a href="https://doi.org/10.1161/01.res.84.9.989" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10325236/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circ.%20Res.&amp;title=Mechanism%20of%20Block%20and%20Identification%20of%20the%20Verapamil%20Binding%20Domain%20to%20HERG%20Potassium%20Channels&amp;author=S.%20Zhang&amp;author=Z.%20Zhou&amp;author=Q.%20Gong&amp;author=J.%20C.%20Makielski&amp;author=C.%20T.%20January&amp;volume=84&amp;publication_year=1999&amp;pages=989-998&amp;pmid=10325236&amp;doi=10.1161/01.res.84.9.989&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B82">
<cite>
Zhang S., Kehl S. J., Fedida D. (2003). Modulation of Human Ether-A-Go-Go-Related K+ (HERG) Channel Inactivation by Cs+ and K+. J. Physiol.
548, 691–702. 10.1113/jphysiol.2003.039198
</cite> [<a href="https://doi.org/10.1113/jphysiol.2003.039198" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2342897/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12626667/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Physiol.&amp;title=Modulation%20of%20Human%20Ether-A-Go-Go-Related%20K+%20(HERG)%20Channel%20Inactivation%20by%20Cs+%20and%20K+&amp;author=S.%20Zhang&amp;author=S.%20J.%20Kehl&amp;author=D.%20Fedida&amp;volume=548&amp;publication_year=2003&amp;pages=691-702&amp;pmid=12626667&amp;doi=10.1113/jphysiol.2003.039198&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B83">
<cite>
Zhang S. (2006). Isolation and Characterization of IKr in Cardiac Myocytes by Cs+ Permeation. Am. J. Physiology-Heart Circulatory Physiol.
290, H1038–H1049. 10.1152/ajpheart.00679.2005
</cite> [<a href="https://doi.org/10.1152/ajpheart.00679.2005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16227343/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Physiology-Heart%20Circulatory%20Physiol.&amp;title=Isolation%20and%20Characterization%20of%20IKr%20in%20Cardiac%20Myocytes%20by%20Cs+%20Permeation&amp;author=S.%20Zhang&amp;volume=290&amp;publication_year=2006&amp;pages=H1038-H1049&amp;pmid=16227343&amp;doi=10.1152/ajpheart.00679.2005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B84">
<cite>
Zhao Z., Li X., El‐Battrawy I., Lan H., Zhong R., Xu Q., et al.  (2019). Drug Testing in Human‐Induced Pluripotent Stem Cell-Derived Cardiomyocytes from a Patient with Short QT Syndrome Type 1. Clin. Pharmacol. Ther.
106, 642–651. 10.1002/cpt.1449
</cite> [<a href="https://doi.org/10.1002/cpt.1449" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30947366/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Pharmacol.%20Ther.&amp;title=Drug%20Testing%20in%20Human%E2%80%90Induced%20Pluripotent%20Stem%20Cell-Derived%20Cardiomyocytes%20from%20a%20Patient%20with%20Short%20QT%20Syndrome%20Type%201&amp;author=Z.%20Zhao&amp;author=X.%20Li&amp;author=I.%20El%E2%80%90Battrawy&amp;author=H.%20Lan&amp;author=R.%20Zhong&amp;volume=106&amp;publication_year=2019&amp;pages=642-651&amp;pmid=30947366&amp;doi=10.1002/cpt.1449&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B85">
<cite>
Zhou Z., Gong Q., Ye B., Fan Z., Makielski J. C., Robertson G. A., et al.  (1998). Properties of HERG Channels Stably Expressed in HEK 293 Cells Studied at Physiological Temperature. Biophysical J.
74, 230–241. 10.1016/s0006-3495(98)77782-3
</cite> [<a href="https://doi.org/10.1016/s0006-3495(98)77782-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1299377/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9449325/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biophysical%20J.&amp;title=Properties%20of%20HERG%20Channels%20Stably%20Expressed%20in%20HEK%20293%20Cells%20Studied%20at%20Physiological%20Temperature&amp;author=Z.%20Zhou&amp;author=Q.%20Gong&amp;author=B.%20Ye&amp;author=Z.%20Fan&amp;author=J.%20C.%20Makielski&amp;volume=74&amp;publication_year=1998&amp;pages=230-241&amp;pmid=9449325&amp;doi=10.1016/s0006-3495(98)77782-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ol></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/8138577/bin/DataSheet1.pdf" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (186.4KB, pdf) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The original contributions presented in the study are included in the article/<a href="#s11" class="usa-link">Supplementary Material</a>, further inquiries can be directed to the corresponding author.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Frontiers in Pharmacology are provided here courtesy of <strong>Frontiers Media SA</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.3389/fphar.2021.675003"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/fphar-12-675003.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (3.2 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/8138577/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/8138577/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC8138577%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC8138577/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC8138577/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC8138577/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/34025432/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC8138577/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/34025432/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC8138577/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/8138577/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="yGxcqWky1LDZ51YcbTJzrLQ10R4o2543tR51Ecta68zNwQh70YUUlt9uAn9PBeHF">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
